Document:

Exhibit 4.2 

 

META
PLATFORMS, INC.

 

3.500% Senior
Notes due 2027

 

3.850% Senior
Notes due 2032

 

4.450% Senior
Notes due 2052

 

4.650% Senior
Notes due 2062

 

 

First Supplemental
Indenture

 

Dated as of
August 9, 2022

 

 

 

U.S. BANK TRUST
COMPANY, NATIONAL ASSOCIATION, as

Trustee

 

 

     

     

    

TABLE OF CONTENTS

 

Page

 

	Article
    One  CERTAIN DEFINITIONS	2
	Article Two 
    SCOPE OF SUPPLEMENTAL INDENTURE; GENERAL	4
	Article Three 
    THE NOTES	8
	Section
    3.01.  Form and Dating	8
	Article Four 
    REDEMPTION	8
	Section
    4.01.  Redemption at the Option of the Company.	8
	Article Five 
    MISCELLANEOUS	11
	Section
    5.01.  Governing Laws; Waiver of Jury Trial.	11
	Section
    5.02.  No Adverse Interpretation of Other Agreements.	11
	Section
    5.03.  Successors and Assigns.	11
	Section
    5.04.  Severability.	11
	Section
    5.05.  Force Majeure.	11
	Section
    5.06.  Table of Contents, Headings, Etc.	12
	Section
    5.07.  Counterparts.	12
	Section
    5.08.  Confirmation of Indenture.	12
	Section
    5.09.  Trustee Disclaimer.	12

 

     

     

    

	APPENDIX A Provisions Relating to Initial Notes and Exchange Notes	A-1
	EXHIBIT A Form of 2027 Note	Ex-A-1
	EXHIBIT B Form of 2032 Note	Ex-B-1
	EXHIBIT C Form of 2052 Note	Ex-C-1
	EXHIBIT D Form of 2062 Note	Ex-D-1
	EXHIBIT E Restricted Securities Legend	Ex-E-1
	EXHIBIT F Regulation S Certificate	Ex-F-1
	EXHIBIT G Rule 144A Certificate	Ex-G-1

 

     

     

    

SUPPLEMENTAL INDENTURE
dated as of August 9, 2022 (this “Supplemental Indenture”), to the Indenture dated as of August 9, 2022 (the “Base
Indenture” and, together with the Supplemental Indenture, the “Indenture”), by and between META PLATFORMS,
INC., a Delaware corporation (the “Company”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee (the “Trustee”).

 

Each party agrees
as follows for the benefit of the other parties and for the equal and ratable benefit of the Holders (as defined herein):

 

WHEREAS, the Company
and the Trustee have duly authorized the execution and delivery of the Base Indenture to provide for the issuance from time to time of
the Company’s debentures, notes or other debt instruments to be issued in one or more Series as in the Base Indenture provided
(as defined therein, “Securities”);

 

WHEREAS, the Company
desires and has requested the Trustee to join in the execution and delivery of this Supplemental Indenture in order to establish and
provide for the issuance by the Company of four Series of Securities designated as its 3.500% Senior Notes due 2027 (the “2027
Notes”), its 3.850% Senior Notes due 2032 (the “2032 Notes”), its 4.450% Senior Notes due 2052 (the “2052
Notes”) and its 4.650% Senior Notes due 2062 (the “2062 Notes” and, together with the 2027 Notes, 2032 Notes
and 2052 Notes, the “Initial Notes”), substantially in the forms attached hereto as Exhibit A, Exhibit B,
Exhibit C and Exhibit D, respectively, on the terms set forth herein, together with any Exchange Notes (as defined in Appendix
A hereto) issued therefor as provided herein (the Initial Notes and the Exchange Notes, are together referred to herein as the “Notes”);

 

WHEREAS, Section
2.01 of the Base Indenture provides that a supplemental indenture may be entered into by the Company and the Trustee for such purpose,
without the consent of Holders, provided certain conditions are met;

 

WHEREAS, the conditions
set forth in the Base Indenture for the execution and delivery of this Supplemental Indenture have been complied with; and

 

WHEREAS, all things
necessary to make this Supplemental Indenture a valid agreement of the Company and the Trustee, in accordance with its terms, and a valid
amendment of, and supplement to, the Base Indenture have been done;

 

     

     

    

NOW, THEREFORE:

 

In consideration
of the premises and the purchase and acceptance of the Notes by the Holders thereof, the Company covenants and agrees with the Trustee,
for the equal and ratable benefit of the Holders, that the Base Indenture is supplemented and amended, to the extent expressed herein,
as follows:

 

Article
One

CERTAIN DEFINITIONS

 

The following terms
have the meanings set forth below in this Supplemental Indenture. Capitalized terms used but not defined herein have the meanings ascribed
to such terms in the Base Indenture. To the extent terms defined herein differ from the Base Indenture the terms defined herein will
govern.

 

“Company”
has the meaning provided in the Base Indenture.

 

“Holder”
means the Person in whose name a Note is registered in the books of the Registrar for the Notes.

 

“Indenture”
has the meaning provided in the Preamble.

 

“Notes”
has the meaning provided in the Recitals.

 

“Par Call
Date” means the 2027 Par Call Date, the 2032 Par Call Date, the 2052 Par Call Date or the 2062 Par Call Date, as applicable.

 

“Paying
Agent” means U.S. Bank Trust Company, National Association or any successor paying agent.

 

“Redemption
Date” means, with respect to any Note of any Series to be redeemed, the date fixed for such redemption by or pursuant to this
Supplemental Indenture.

 

“Registrar”
means U.S. Bank Trust Company, National Association, or any successor registrar of the Notes.

 

“Supplemental
Indenture” has the meaning provided in the Preamble.

 

“Treasury
Rate” means, with respect to any Redemption Date in respect of the Notes of any Series, the yield determined by the Company
in accordance with the following two paragraphs:

 

(1)  The
Treasury Rate shall be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government
securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the Redemption
Date based upon the yield or yields for the most

 

    2 

     

    

recent day that appear
after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System
designated as “Selected Interest Rates (Daily) - H.15” (or any successor designation or publication) (“H.15”)
under the caption “U.S. government securities–Treasury constant maturities–Nominal” (or any successor caption
or heading) (“H.15 TCM”). In determining the Treasury Rate, the Company shall select, as applicable: (x) the yield for the
Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the applicable Par Call Date (the “Remaining
Life”); or (y) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields –
one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury
constant maturity on H.15 immediately longer than the Remaining Life – and shall interpolate to the applicable Par Call Date on
a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (z) if
there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury
constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or
maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury
constant maturity from the Redemption Date.

 

(2)  If
on the third Business Day preceding the Redemption Date H.15 TCM (or any successor designation) is no longer published, the Company shall
calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York
City time, on the second Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity
that is closest to, the applicable Par Call Date. If there is no United States Treasury security maturing on the applicable Par Call
Date but there are two or more United States Treasury securities with a maturity date equally distant from such Par Call Date, one with
a maturity date preceding such Par Call Date and one with a maturity date following such Par Call Date, the Company shall select the
United States Treasury security with a maturity date preceding such Par Call Date. If there are two or more United States Treasury securities
maturing on the applicable Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence,
the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading
closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York
City time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the
applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of
principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places.

 

“Trustee”
has the meaning provided in the Preamble.

 

    3 

     

    

Article
Two

SCOPE OF SUPPLEMENTAL INDENTURE; GENERAL

 

Section 2.01.

 

The changes, modifications and supplements
to the Base Indenture effected by this Supplemental Indenture shall be applicable only with respect to, and govern the terms of, the
Notes, which shall not be limited in aggregate principal amount, and shall not apply to any other Securities that may be issued under
the Base Indenture unless a supplemental indenture with respect to such other Securities specifically incorporates such changes, modifications
and supplements.

 

(a)  
Pursuant to this Supplemental Indenture, there is hereby created and designated four Series of Securities under the Base Indenture
entitled the “3.500% Senior Notes due 2027,” “3.850% Senior Notes due 2032,” “4.450% Senior Notes due 2052,”
and the “4.650% Senior Notes due 2062”.

 

(b)  
The 2027 Notes shall be in the form of Exhibit A hereto (the “Specimen 2027 Note”), which is hereby
incorporated into this Supplemental Indenture by reference. The terms of the 2027 Notes shall be as follows:

 

(i)  
The 2027 Notes are to be issued initially in an aggregate principal amount of $2,750,000,000; provided however, that the aggregate
principal amount of the 2027 Notes which may be outstanding may be increased by the Company upon the terms and subject to the conditions
set forth in the Indenture and the 2027 Notes.

 

(ii)  
The 2027 Notes will mature on August 15, 2027.

 

(iii)  
The 2027 Notes will bear interest at a rate of 3.500% per annum.

 

(iv)  
The date from which interest shall accrue, the payment dates on which interest shall be payable and the regular record date for
the interest payable on any payment date will be as set forth in the Specimen 2027 Note.

 

(v)  
Principal and interest on the 2027 Notes are payable at the Corporate Trust Office, except as otherwise provided in the Specimen
2027 Note.

 

(vi)  
The 2027 Notes shall be redeemable at the redemption prices and on the terms set forth in Article 4 of this Supplemental Indenture.
Except as otherwise provided in Article 4 of this Supplemental Indenture, redemption of the 2027 Notes shall be made in accordance with
the terms of Article 3 of the Base Indenture.

 

(vii)  
The 2027 Notes will not be subject to any sinking fund.

 

(viii)  
The 2027 Notes are issuable in denominations of $2,000 and integral multiples of $1,000 in excess thereof.

 

    4 

     

    

(ix)  
The 2027 Notes are to be issued initially as Registered Global Securities. Beneficial owners of interests in the 2027 Notes may
exchange such interests in accordance with the Indenture and the terms of the 2027 Notes.

 

(x)  
The “Depositary” with respect to the 2027 Notes will initially be the Depository Trust Company (“DTC”).

 

(xi)  
Interest on the 2027 Notes will be computed and paid on the basis of a 360-day year of twelve 30-day months.

 

(xii)  
The terms of the 2027 Notes shall include such other terms as are set forth in the Specimen 2027 Note and in the Indenture. To
the extent the terms of the Indenture and the Specimen 2027 Note are inconsistent, the terms of the Specimen 2027 Note will govern.

 

(c)  
The 2032 Notes shall be in the form of Exhibit B hereto (the “Specimen 2032 Note”), which is hereby
incorporated into this Supplemental Indenture by reference. The terms of the 2032 Notes shall be as follows:

 

(i)  
The 2032 Notes are to be issued initially in an aggregate principal amount of $3,000,000,000; provided however, that the aggregate
principal amount of the 2032 Notes which may be outstanding may be increased by the Company upon the terms and subject to the conditions
set forth in the Indenture and the 2032 Notes.

 

(ii)  
The 2032 Notes will mature on August 15, 2032.

 

(iii)  
The 2032 Notes will bear interest at a rate of 3.850% per annum.

 

(iv)  
The date from which interest shall accrue, the payment dates on which interest shall be payable and the regular record date for
the interest payable on any payment date will be as set forth in the Specimen 2032 Note.

 

(v)  
Principal and interest on the 2032 Notes are payable at the Corporate Trust Office, except as otherwise provided in the Specimen
2032 Note.

 

(vi)  
The 2032 Notes shall be redeemable at the redemption prices and on the terms set forth in Article 4 of this Supplemental Indenture.
Except as otherwise provided in Article 4 of this Supplemental Indenture, redemption of the 2032 Notes shall be made in accordance with
the terms of Article 3 of the Base Indenture.

 

(vii)  
The 2032 Notes will not be subject to any sinking fund.

 

(viii)  
The 2032 Notes are issuable in denominations of $2,000 and integral multiples of $1,000 in excess thereof.

 

    5 

     

    

(ix)  
The 2032 Notes are to be issued initially as Registered Global Securities. Beneficial owners of interests in the 2032 Notes may
exchange such interests in accordance with the Indenture and the terms of the 2032 Notes.

 

(x)  
The “Depositary” with respect to the 2032 Notes will initially be DTC.

 

(xi)  
Interest on the 2032 Notes will be computed and paid on the basis of a 360-day year of twelve 30-day months.

 

(xii)  
The terms of the 2032 Notes shall include such other terms as are set forth in the Specimen 2032 Note and in the Indenture. To
the extent the terms of the Indenture and the Specimen 2032 Note are inconsistent, the terms of the Specimen 2032 Note will govern.

 

(d)  
The 2052 Notes shall be in the form of Exhibit C hereto (the “Specimen 2052 Note”), which is hereby
incorporated into this Supplemental Indenture by reference. The terms of the 2052 Notes shall be as follows:

 

(i)  
The 2052 Notes are to be issued initially in an aggregate principal amount of $2,750,000,000; provided however, that the aggregate
principal amount of the 2052 Notes which may be outstanding may be increased by the Company upon the terms and subject to the conditions
set forth in the Indenture and the 2052 Notes.

 

(ii)  
The 2052 Notes will mature on August 15, 2052.

 

(iii)  
The 2052 Notes will bear interest at a rate of 4.450% per annum.

 

(iv)  
The date from which interest shall accrue, the payment dates on which interest shall be payable and the regular record date for
the interest payable on any payment date will be as set forth in the Specimen 2052 Note.

 

(v)  
Principal and interest on the 2052 Notes are payable at the Corporate Trust Office, except as otherwise provided in the Specimen
2052 Note.

 

(vi)  
The 2052 Notes shall be redeemable at the redemption prices and on the terms set forth in Article 4 of this Supplemental Indenture.
Except as otherwise provided in Article 4 of this Supplemental Indenture, redemption of the 2052 Notes shall be made in accordance with
the terms of Article 3 of the Base Indenture.

 

(vii)  
The 2052 Notes will not be subject to any sinking fund.

 

(viii)  
The 2052 Notes are issuable in denominations of $2,000 and integral multiples of $1,000 in excess thereof.

 

    6 

     

    

(ix)  
The 2052 Notes are to be issued initially as Registered Global Securities. Beneficial owners of interests in the 2052 Notes may
exchange such interests in accordance with the Indenture and the terms of the 2052 Notes.

 

(x)  
The “Depositary” with respect to the 2052 Notes will initially be DTC.

 

(xi)  
Interest on the 2052 Notes will be computed and paid on the basis of a 360-day year of twelve 30-day months.

 

(xii)  
The terms of the 2052 Notes shall include such other terms as are set forth in the Specimen 2052 Note and in the Indenture. To
the extent the terms of the Indenture and the Specimen 2052 Note are inconsistent, the terms of the Specimen 2052 Note will govern.

 

(e)  
The 2062 Notes shall be in the form of Exhibit D hereto (the “Specimen 2062 Note”), which is hereby
incorporated into this Supplemental Indenture by reference. The terms of the 2062 Notes shall be as follows:

 

(i)  
The 2062 Notes are to be issued initially in an aggregate principal amount of $1,500,000,000; provided however, that the aggregate
principal amount of the 2062 Notes which may be outstanding may be increased by the Company upon the terms and subject to the conditions
set forth in the Indenture and the 2062 Notes.

 

(ii)  
The 2062 Notes will mature on August 15, 2062.

 

(iii)  
The 2062 Notes will bear interest at a rate of 4.650% per annum.

 

(iv)  
The date from which interest shall accrue, the payment dates on which interest shall be payable and the regular record date for
the interest payable on any payment date will be as set forth in the Specimen 2062 Note.

 

(v)  
Principal and interest on the 2062 Notes are payable at the Corporate Trust Office, except as otherwise provided in the Specimen
2062 Note.

 

(vi)  
The 2062 Notes shall be redeemable at the redemption prices and on the terms set forth in Article 4 of this Supplemental Indenture.
Except as otherwise provided in Article 4 of this Supplemental Indenture, redemption of the 2062 Notes shall be made in accordance with
the terms of Article 3 of the Base Indenture.

 

(vii)  
The 2062 Notes will not be subject to any sinking fund.

 

(viii)  
The 2062 Notes are issuable in denominations of $2,000 and integral multiples of $1,000 in excess thereof.

 

    7 

     

    

(ix)  
The 2062 Notes are to be issued initially as Registered Global Securities. Beneficial owners of interests in the 2062 Notes may
exchange such interests in accordance with the Indenture and the terms of the 2062 Notes.

 

(x)  
The “Depositary” with respect to the 2062 Notes will initially be DTC.

 

(xi)  
Interest on the 2062 Notes will be computed and paid on the basis of a 360-day year of twelve 30-day months.

 

(xii)  
The terms of the 2062 Notes shall include such other terms as are set forth in the Specimen 2062 Note and in the Indenture. To
the extent the terms of the Indenture and the Specimen 2062 Note are inconsistent, the terms of the Specimen 2062 Note will govern.

 

Article
Three

THE NOTES

 

Section 3.01.  
Form and Dating. Provisions relating to the Initial Notes and the Exchange Notes are set forth in Appendix A, which is
hereby incorporated in and expressly made part of this Supplemental Indenture.

 

Article
Four

REDEMPTION

 

The following provision
shall apply with respect to the Notes:

 

Section 4.01.  
Redemption at the Option of the Company.

 

(a)  
The Company may redeem the 2027 Notes, at its option, in whole or in part, at any time and from time to time prior to July 15,
2027 (one month prior to the maturity date of the 2027 Notes) (the “2027 Par Call Date”), in principal amounts of $1,000
and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2027 Note must be in a minimum principal
amount of $2,000, for a redemption price equal to the greater of:

 

(i)  
(a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption
Date (assuming the 2027 Notes matured on the 2027 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the Treasury Rate plus 15 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii)  
100% of the principal amount of the 2027 Notes to be redeemed,

 

    8 

     

    

plus, in
each case, accrued and unpaid interest to, but excluding, the Redemption Date.

 

(b)  
The Company may redeem the 2027 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2027
Par Call Date, in principal amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion
of a 2027 Note must be in a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2027
Notes being redeemed plus accrued and unpaid interest to the Redemption Date.

 

(c)  
The Company may redeem the 2032 Notes, at its option, in whole or in part, at any time and from time to time prior to May 15,
2032 (three months prior to the maturity date of the 2032 Notes) (the “2032 Par Call Date”), in principal amounts of $1,000
and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2032 Note must be in a minimum principal
amount of $2,000, for a redemption price equal to the greater of:

 

(i)  
(a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption
Date (assuming the 2032 Notes matured on the 2032 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the Treasury Rate plus 20 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii)  
100% of the principal amount of the 2032 Notes to be redeemed,

 

plus, in
each case, accrued and unpaid interest to, but excluding, the Redemption Date.

 

(d)  
The Company may redeem the 2032 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2032
Par Call Date, in principal amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion
of a 2032 Note must be in a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2032
Notes being redeemed plus accrued and unpaid interest to the Redemption Date.

 

(e)  
The Company may redeem the 2052 Notes, at its option, in whole or in part, at any time and from time to time prior to February
15, 2052 (six months prior to the maturity date of the 2052 Notes) (the “2052 Par Call Date”), in principal amounts of $1,000
and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2052 Note must be in a minimum principal
amount of $2,000, for a redemption price equal to the greater of:

 

(i)  
(a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption
Date (assuming the 2052 Notes matured on the 2052 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the

 

    9 

     

    

Treasury
Rate plus 25 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii)  
100% of the principal amount of the 2052 Notes to be redeemed,

 

plus, in
each case, accrued and unpaid interest to, but excluding, the Redemption Date.

 

(f)  
The Company may redeem the 2052 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2052
Par Call Date, in principal amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion
of a 2052 Note must be in a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2052
Notes being redeemed plus accrued and unpaid interest to the Redemption Date.

 

(g)  
The Company may redeem the 2062 Notes, at its option, in whole or in part, at any time and from time to time prior to February
15, 2062 (six months prior to the maturity date of the 2062 Notes) (the “2062 Par Call Date”), in principal amounts of $1,000
and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2062 Note must be in a minimum principal
amount of $2,000, for a redemption price equal to the greater of:

 

(i)  
(a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption
Date (assuming the 2062 Notes matured on the 2062 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve
30-day months) at the Treasury Rate plus 25 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii)  
100% of the principal amount of the 2062 Notes to be redeemed,

 

plus, in
each case, accrued and unpaid interest to, but excluding, the Redemption Date.

 

(h)  
The Company may redeem the 2062 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2062
Par Call Date, in principal amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion
of a 2062 Note must be in a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2062
Notes being redeemed plus accrued and unpaid interest to the Redemption Date.

 

(i)  
With respect to any redemption of the Notes of any Series occurring prior to the applicable Par Call Date, the Company shall give
the Trustee notice of the related redemption price promptly after the calculation thereof and the Trustee shall not have any responsibility
for such calculation.

 

    10 

     

    

Article
Five

MISCELLANEOUS

 

Section 5.01.  
Governing Laws; Waiver of Jury Trial.

 

THIS SUPPLEMENTAL
INDENTURE AND EACH NOTE SHALL BE DEEMED TO BE A CONTRACT UNDER THE LAWS OF THE STATE OF NEW YORK, AND FOR ALL PURPOSES SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF SUCH STATE, INCLUDING, WITHOUT LIMITATION, SECTIONS 5-1401 AND 5- 1402 OF THE NEW YORK
GENERAL OBLIGATIONS LAW AND NEW YORK CIVIL PRACTICE LAWS AND RULES 327(b).

 

EACH OF THE COMPANY
AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY
LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY.

 

Section 5.02.  
No Adverse Interpretation of Other Agreements.

 

This Supplemental
Indenture may not be used to interpret another indenture (other than the Base Indenture), loan or debt agreement of the Company or a
Subsidiary. Any such indenture, loan or debt agreement may not be used to interpret this Supplemental Indenture (other than the Base
Indenture).

 

Section 5.03.  
Successors and Assigns.

 

All agreements of
the Company in this Supplemental Indenture and the Notes shall bind its successor. All agreements of the Trustee in this Supplemental
Indenture shall bind its successor.

 

Section 5.04.  
Severability.

 

In case any provision
in this Supplemental Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

 

Section 5.05.  
Force Majeure.

 

In no event shall
the Trustee or any Agent be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out
of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents,
acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or
malfunctions of utilities, communications or computer (software and hardware) services; it being understood that

 

    11 

     

    

the Trustee and such
Agent shall use reasonable efforts that are consistent with accepted practices in the banking industry to resume performance as soon
as practicable under the circumstances.

 

Section 5.06.  
Table of Contents, Headings, Etc.

 

The Table of Contents,
Cross Reference Table, and headings of the Articles and Sections of this Supplemental Indenture have been inserted for convenience of
reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.

 

Section 5.07.  
Counterparts. This Supplemental Indenture may be executed in any number of counterparts and by the parties hereto in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and
the same agreement. Delivery of an executed counterpart of a signature page of this Supplemental Indenture by facsimile or other electronic
imaging means shall be effective as delivery of a manually executed counterpart of this Indenture.

 

The Trustee shall
not have any duty to confirm that the person sending any notice, instruction or other communication by electronic transmission (including
by e-mail, facsimile transmission, web portal or other electronic methods) is, in fact, a person authorized to do so. Electronic signatures
believed by the Trustee to comply with the ESIGN Act of 2000 or other applicable law (including electronic images of handwritten signatures
and digital signatures provided by DocuSign, Orbit, Adobe Sign or any other digital signature provider acceptable to the Trustee) shall
be deemed original signatures for all purposes. The Company assumes all risks arising out of the use of electronic signatures and electronic
methods to send communications to the Trustee, including without limitation the risk of the Trustee acting on an unauthorized communication,
and the risk of interception or misuse by third parties.

 

Section 5.08.  
Confirmation of Indenture. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects
ratified and confirmed, and the Base Indenture, this Supplemental Indenture and all indentures supplemental thereto with respect to the
Notes shall be read, taken and construed as one and the same instrument. 

 

Section 5.09.  
Trustee Disclaimer. The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture
other than as to the validity of its execution and delivery by the Trustee. The recitals and statements herein are deemed to be those
of the Company and not the Trustee.

 

    12 

     

    

SIGNATURES

 

IN WITNESS WHEREOF,
the parties have caused this Supplemental Indenture to be duly executed, all as of the date first above

 

	 	META PLATFORMS, INC.
	 	 
	 	 
	 	By:	/s/ David M. Wehner
	 	 	Name:	David M. Wehner
	 	 	Title:	Chief Financial Officer

 

[Signature Page
to Supplemental Indenture]

     

     

    

	U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,	 
	as Trustee	 
	 	 	 
	 	 	 
	By:	/s/ David Jason              	 
	Name:	David Jason 	 
	Title:	Vice President 	 

 

[Signature Page
to Supplemental Indenture]

 

     

     

    

Appendix A

 

PROVISIONS
RELATING TO INITIAL NOTES

AND EXCHANGE NOTES

 

1.
Definitions

 

1.1  
Definitions

 

For the purposes
of this Appendix A the following terms shall have the meanings indicated below. Capitalized terms used but not defined herein have the
meanings ascribed to such terms in the Indenture. To the extent terms defined herein differ from the Indenture the terms defined herein
will govern.

 

“Additional
Interest” means additional interest owed to the Holders pursuant to a Registration Rights Agreement.

 

“Additional
Notes” means any Notes of any Series issued under the Indenture in addition to the Original Notes of such Series, including
any Exchange Notes issued in exchange for such Additional Notes, having the same terms in all respects as the Original Notes of such
Series, or in all respects except with respect to interest paid or payable on or prior to the first interest payment date after the issuance
of such Additional Notes.

 

“Agent
Member” means a member of, or a participant in, the Depositary.

 

“Certificated
Note” means a Note in registered individual form without interest coupons.

 

“Depositary”
means the depositary of each Global Note, which initially will be DTC.

 

“DTC”
means The Depository Trust Company, a New York corporation, and its successors.

 

“Exchange
Notes” means the Notes of any Series issued pursuant to the Indenture in exchange for, and in an aggregate principal amount
equal to, the Initial Notes or any Initial Additional Notes of such Series, in compliance with the terms of a Registration Rights Agreement
and containing terms substantially identical to the Initial Notes or any Initial Additional Notes of such Series (except that (i) such
Exchange Notes will be registered under the Securities Act and will not be subject to transfer restrictions or bear the Restricted Legend,
and (ii) the provisions relating to Additional Interest will be eliminated).

 

“Global
Note” means a Note in registered global form without interest coupons.

 

“Holder”
or “Noteholder” means the registered holder of any Note.

 

    Ex-A-1

     

    

“Initial
Additional Notes” means Additional Notes issued in an offering not registered under the Securities Act and any Notes issued
in replacement thereof, but not including any Exchange Notes issued in exchange therefor.

 

“Initial
Notes” means the Notes of each Series issued on the Issue Date and any Notes issued in replacement thereof, but not including
any Exchange Notes issued in exchange therefor.

 

“Initial
Purchasers” means the initial purchasers party to a purchase agreement with the Company relating to the sale of the Notes or
Additional Notes by the Company.

 

“Issue
Date” means the date on which the Original Notes are originally issued under the Indenture.

 

“Notes”
has the meaning assigned to such terms in the Recitals of this Supplemental Indenture.

 

“Offshore
Global Note” means a Global Note representing Notes issued and sold pursuant to Regulation S.

 

“Original
Notes” means the Initial Notes of each Series and any Exchange Notes issued in exchange therefor.

 

“Person”
means an individual, a corporation, a partnership, a limited liability company, an association, a trust or any other entity, including
a government or political subdivision or an agency or instrumentality thereof.

 

“Registration
Rights Agreement” means (i) the Registration Rights Agreement dated on or about the Issue Date between the Company and the
Initial Purchasers party thereto with respect to the Initial Notes, and (ii) with respect to any Additional Notes, any registration rights
agreements between the Company and the Initial Purchasers party thereto relating to rights given by the Company to the purchasers of
Additional Notes to register such Additional Notes or exchange them for Notes registered under the Securities Act.

 

“Regulation
S” means Regulation S under the Securities Act.

 

“Regulation
S Certificate” means a certificate substantially in the form of Exhibit F hereto.

 

“Restricted
Legend” means the legend set forth in Exhibit E hereto.

 

“Restricted
Period” means the period beginning on the date hereof and ending 40 days thereafter.

 

“Rule 144A”
means Rule 144A under the Securities Act.

 

    A-2

     

    

“Rule 144A
Certificate” means (i) a certificate substantially in the form of Exhibit G hereto or (ii) a written certification addressed
to the Company and the Trustee to the effect that the Person making such certification (x) is acquiring such Note (or beneficial interest)
for its own account or one or more accounts with respect to which it exercises sole investment discretion and that it and each such account
is a qualified institutional buyer within the meaning of Rule 144A, (y) is aware that the transfer to it or exchange, as applicable,
is being made in reliance upon the exemption from the provisions of Section 5 of the Securities Act provided by Rule 144A and (z) acknowledges
that it has received such information regarding the Company as it has requested pursuant to Rule 144A(d)(4) or has determined not to
request such information.

 

“Securities
Act” means the Securities Act of 1933.

 

“U.S. Global
Note” means a Global Note that bears the Restricted Legend representing Notes issued and sold pursuant to Rule 144A.

 

SECTION 2.1. Restricted
Legend. (a) Except as otherwise provided in paragraph (c), each Global Note representing Notes originally sold by the Initial Purchasers
in accordance with Rule 144A will bear the Restricted Legend.

 

(b) Except as otherwise
provided in paragraph (c), Section 2.2(b)(3), (b)(5) or (c) or Section 2.3(b)(4), each Certificated Note will bear the Restricted Legend.

 

(c) (1) If the Company
determines (upon the advice of counsel and such other certifications and evidence as the Company may reasonably require) that a Note
is eligible for resale pursuant to Rule 144 under the Securities Act (or a successor provision) without the need for current public information
and that the Restricted Legend is no longer necessary or appropriate in order to ensure that subsequent transfers of the Note (or a beneficial
interest therein) are effected in compliance with the Securities Act,

 

or (2) after an
Initial Note or any Initial Additional Note is (x) sold pursuant to an effective registration statement under the Securities Act, pursuant
to the Registration Rights Agreement or otherwise, or (y) is validly tendered for exchange into an Exchange Note pursuant to an Exchange
Offer,

 

the Company may instruct the Trustee
to cancel the Note and issue to the Holder thereof (or to its transferee) a new Note of like tenor and amount, registered in the name
of the Holder thereof (or its transferee), that does not bear the Restricted Legend, and the Trustee will comply with such instruction.

 

(d) By its acceptance
of any Note bearing the Restricted Legend (or any beneficial interest in such a Note), each Holder thereof and each owner of a beneficial
interest therein acknowledges the restrictions on transfer of such Note (and any such beneficial interest) set forth in this Indenture
and in the Restricted Legend and agrees that it will transfer such Note (and any such beneficial interest) only in accordance with the
Indenture and such legend.

 

    A-3

     

    

SECTION 2.2. Restrictions
on Transfer and Exchange. (a) The transfer or exchange of any Note (or a beneficial interest therein) may only be made in accordance
with this Section and Section 2.3 and, in the case of a Global Note (or a beneficial interest therein), the applicable rules and procedures
of the Depositary. The Trustee shall refuse to register any requested transfer or exchange that does not comply with the preceding sentence.

 

(b) Subject to paragraph
(c), the transfer or exchange of any Note (or a beneficial interest therein) of the type set forth in column A below for a Note (or a
beneficial interest therein) of the type set forth opposite in column B below may only be made in compliance with the certification requirements
(if any) described in the clause of this paragraph set forth opposite in column C below.

 

	A	B	C
	U.S. Global Note	U.S. Global Note	(1)
	U.S. Global Note	Offshore Global Note	(2)
	U.S. Global Note	Certificated Note	(3)
	Offshore Global Note	U.S. Global Note	(4)
	Offshore Global Note	Offshore Global Note	(1)
	Offshore Global Note	Certificated Note	(5)
	Certificated Note	U.S. Global Note	(4)
	Certificated Note	Offshore Global Note	(2)
	Certificated Note	Certificated Note	(3)

 

		(1)	No certification is required.

 

		(2)	The Person requesting the transfer or
                                            exchange must deliver or cause to be delivered to the Trustee a duly completed Regulation
                                            S Certificate; provided that if the requested transfer or exchange is made by the
                                            Holder of a Certificated Note that does not bear the Restricted Legend, then no certification
                                            is required.

 

		(3)	The Person requesting the transfer or
                                            exchange must deliver or cause to be delivered to the Trustee (x) a duly completed Rule 144A
                                            Certificate or (y) a duly completed Regulation S Certificate and/or an Opinion of Counsel
                                            and such other certifications and evidence as the Company may reasonably require in order
                                            to determine that the proposed transfer or exchange is being made in compliance with the
                                            Securities Act and any applicable securities laws of any state of the United States; provided
                                            that if the requested transfer or exchange is made by the Holder of a Certificated Note
                                            that does not bear the Restricted Legend, then no certification is

 

    A-4

     

    

required.
In the event that (i) the requested transfer or exchange takes place after the Restricted Period and a duly completed Regulation S Certificate
is delivered to the Trustee or (ii) a Certificated Note that does not bear the Restricted Legend is surrendered for transfer or exchange,
upon transfer or exchange the Trustee will deliver a Certificated Note that does not bear the Restricted Legend.

 

		(4)	The Person requesting the transfer or
                                            exchange must deliver or cause to be delivered to the Trustee a duly completed Rule 144A
                                            Certificate.

 

		(5)	If the requested transfer or exchange
                                            takes place during the Restricted Period, the person requesting the transfer or exchange
                                            must deliver or cause to be delivered to the Trustee a duly completed Rule 144A Certificate
                                            and/or an Opinion of Counsel and such other certifications and evidence as the Company may
                                            reasonably require in order to determine that the proposed transfer or exchange is being
                                            made in compliance with the Securities Act and any applicable securities laws of any state
                                            of the United States. If the requested transfer or exchange takes place after the Restricted
                                            Period, no certification is required and the Trustee will deliver a Certificated Note that
                                            does not bear the Restricted Legend.

 

(c) No certification
is required in connection with any transfer or exchange of any Note (or a beneficial interest therein)

 

(1) after
such Note is eligible for resale pursuant to Rule 144 under the Securities Act (or a successor provision) without the need for current
public information, provided that the Company has provided the Trustee with an Officer’s Certificate to that effect, and
the Company may require from any Person requesting a transfer or exchange in reliance upon this clause (1) an opinion of counsel and
any other reasonable certifications and evidence in order to support such certificate; or

 

(2)(x) sold
pursuant to an effective registration statement, pursuant to the Registration Rights Agreement or otherwise or (y) which is validly tendered
for exchange into an Exchange Note pursuant to an Exchange Offer.

 

Any Certificated
Note delivered in reliance upon this paragraph will not bear the Restricted Legend.

 

(d) The Trustee
will retain copies of all certificates, opinions and other documents received in connection with the transfer or exchange of a Note (or
a beneficial interest therein), and the Company will have the right to inspect and make copies thereof at any reasonable time upon written
notice to the Trustee.

 

SECTION 2.3. Registration,
Transfer and Exchange. (a) Registered Form Only. The Notes will be issued in registered form only.

 

    A-5

     

    

(b) Global Notes.
(1) Each Global Note will be registered in the name of the Depositary or its nominee and, so long as DTC is serving as the Depositary
thereof, will bear the following legend:

 

Unless
this certificate is presented by an authorized representative of The Depository Trust Company (the “depositary”),
to the Company or its agent for registration of transfer, exchange, or payment, and any certificate issued is registered in the name
of Cede & Co. or in such other name as is requested by an authorized representative of DTC (and any payment is made to Cede &
Co. or to such other entity as is requested by an authorized representative of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE
OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has a beneficial interest herein.

 

(2) Each Global
Note will be delivered to the Trustee as custodian for the Depositary. Transfers of a Global Note (but not a beneficial interest therein)
will be limited to transfers thereof in whole, but not in part, to the Depositary, its successors or their respective nominees, except
(1) as set forth in Section 2.3(b)(4) and (2) transfers of portions thereof in the form of Certificated Notes may be made upon request
of an Agent Member (for itself or on behalf of a beneficial owner) by written notice given to the Trustee or on behalf of the Depositary
in accordance with customary procedures of the Depositary and in compliance with this Section and Section 2.2.

 

(3) Agent Members
will have no rights under the Indenture with respect to any Global Note held on their behalf by the Depositary, and the Depositary may
be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner and Holder of such Global Note
for all purposes whatsoever. Notwithstanding the foregoing, the Depositary or its nominee may grant proxies and otherwise authorize any
Person (including any Agent Member and any Person that holds a beneficial interest in a Global Note through an Agent Member) to take
any action which a Holder is entitled to take under the Indenture or the Notes, and nothing herein will impair, as between the Depositary
and its Agent Members, the operation of customary practices governing the exercise of the rights of a holder of any security.

 

(4) If (x) the Depositary
notifies the Company that it is unwilling or unable to continue as Depositary for a Global Note and a successor depositary is not appointed
by the Company within 90 days of the notice or (y) an Event of Default has occurred and is continuing and the Trustee has received a
request from the Depositary, the Trustee will

 

    A-6

     

    

promptly exchange
each beneficial interest in the Global Note for one or more Certificated Notes in authorized denominations having an equal aggregate
principal amount registered in the name of the owner of such beneficial interest, as identified to the Trustee by the Depositary, and
thereupon the Global Note will be deemed canceled. If such Note was an Offshore Global Note, then the Certificated Notes issued in exchange
therefor will not bear the Restricted Legend.

 

(c) Certificated
Notes. Each Certificated Note will be registered in the name of the Holder thereof or its nominee.

 

(d) Transfers
and Exchanges Generally. A Holder may transfer a Note (or a beneficial interest therein) to another Person or exchange a Note (or
a beneficial interest therein) for another Note or Notes of any authorized denomination by presenting to the Trustee a written request
therefor stating the name of the proposed transferee or requesting such an exchange, accompanied by any certification, opinion or other
document required by Section 2.2. The Trustee will promptly register any such transfer or exchange that meets the requirements of this
Section by noting the same in the register maintained by the Trustee for the purpose; provided that (x) no transfer or exchange
will be effective until the transfer or exchange is registered in such register and (y) the Trustee will not be required (i) to issue,
register the transfer of or exchange any Note for a period of 15 days before a selection of Notes to be redeemed or purchased pursuant
to an Offer to Purchase, (ii) to register the transfer of or exchange any Note so selected for redemption or purchase in whole or in
part, except, in the case of a partial redemption (or purchase), that portion of any Note not being redeemed or purchased, or (iii) if
a redemption or a purchase pursuant to an Offer to Purchase is to occur after a Regular Record Date but on or before the corresponding
Interest Payment Date, to register the transfer of or exchange any Note on or after the Regular Record Date and before the date of redemption
or purchase. Prior to the registration of any transfer, the Company, the Trustee and their agents will treat the person in whose name
the Note is registered as the owner and Holder thereof for all purposes (whether or not the Note is overdue), and will not be affected
by notice to the contrary.

 

From time to time
the Company will execute and the Trustee will authenticate additional Notes as necessary in order to permit the registration of a transfer
or exchange in accordance with this Section.

 

No service charge
will be imposed in connection with any transfer or exchange of any Note, but the Company may require payment of a sum sufficient to cover
any transfer tax or similar governmental charge payable in connection therewith (other than a transfer tax or other similar governmental
charge payable upon exchange pursuant to paragraph (b)(4)).

 

(e) Procedures
to Be Followed by the Trustee. (1) Global Note to Global Note. If a beneficial interest in a Global Note is transferred or
exchanged for a beneficial interest in another Global Note, the Trustee will (x) record a decrease in the principal amount of the Global
Note being transferred or exchanged equal to the principal amount of such transfer or exchange and (y) record a like increase in the
principal amount of the other

 

    A-7

     

    

Global Note. Any beneficial
interest in one Global Note that is transferred to a Person who takes delivery in the form of an interest in another Global Note, or
exchanged for an interest in another Global Note, will, upon transfer or exchange, cease to be an interest in such Global Note and become
an interest in the other Global Note and, accordingly, will thereafter be subject to all transfer and exchange restrictions, if any,
and other procedures applicable to beneficial interests in such other Global Note for as long as it remains such an interest.

 

(2) Global Note
to Certificated Note. If a beneficial interest in a Global Note is transferred or exchanged for a Certificated Note, the Trustee
will (x) record a decrease in the principal amount of such Global Note equal to the principal amount of such transfer or exchange and
(y) deliver one or more new Certificated Notes in authorized denominations having an equal aggregate principal amount to the transferee
(in the case of a transfer) or the owner of such beneficial interest (in the case of an exchange), registered in the name of such transferee
or owner, as applicable.

 

(3) Certificated
Note to Global Note. If a Certificated Note is transferred or exchanged for a beneficial interest in a Global Note, the Trustee will
(x) cancel such Certificated Note, (y) record an increase in the principal amount of such Global Note equal to the principal amount of
such transfer or exchange and (z) in the event that such transfer or exchange involves less than the entire principal amount of the canceled
Certificated Note, deliver to the Holder thereof one or more new Certificated Notes in authorized denominations having an aggregate principal
amount equal to the untransferred or unexchanged portion of the canceled Certificated Note, registered in the name of the Holder thereof.

 

(4) Certificated Note to Certificated
Note. If a Certificated Note is transferred or exchanged for another Certificated Note, the Trustee will (x) cancel the Certificated
Note being transferred or exchanged, (y) deliver one or more new Certificated Notes in authorized denominations having an aggregate principal
amount equal to the principal amount of such transfer or exchange to the transferee (in the case of a transfer) or the Holder of the
canceled Certificated Note (in the case of an exchange), registered in the name of such transferee or Holder, as applicable, and (z)
if such transfer or exchange involves less than the entire principal amount of the canceled Certificated Note, deliver to the Holder
thereof one or more new Certificated Notes in authorized denominations having an aggregate principal amount equal to the untransferred
or unexchanged portion of the canceled Certificated Note, registered in the name of the Holder thereof.

 

    A-8

     

    

EXHIBIT A

 

FORM

 

OF

 

3.500% SENIOR NOTE
DUE 2027

 

    Ex-A-1

     

    

[FORM OF FACE OF
NOTE]

 

THE SECURITY (OR ITS PREDECESSOR) EVIDENCED
HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE
ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THE SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED
THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.
THE HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT OF THE ISSUER THAT:

 

		(A)	SUCH SECURITY MAY BE OFFERED, RESOLD,
                                            PLEDGED OR OTHERWISE TRANSFERRED, ONLY:

 

		(i)	(a) TO A PERSON WHO THE SELLER REASONABLY
                                            BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES
                                            ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (b)
                                            IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES ACT, (c) OUTSIDE
                                            THE UNITED STATES TO A NON-U.S. PERSON IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE
                                            903 OR 904 UNDER THE SECURITIES ACT OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE
                                            REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL AND
                                            OTHER CERTIFICATIONS AND DOCUMENTS IF THE ISSUER SO REQUESTS);

 

		(ii)	TO THE ISSUER; OR

 

		(iii)	PURSUANT TO AN EFFECTIVE REGISTRATION
                                            STATEMENT

 

AND, IN EACH CASE, IN ACCORDANCE WITH
ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND IN EACH CASE SUBJECT TO ANY
REQUIREMENT OF LAW THAT THE DISPOSITION OF THIS SECURITY BY THE HOLDER OR BY ANY INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN
ITS OR THEIR CONTROL.

 

THIS SECURITY IS
A REGISTERED GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
TRUST COMPANY (THE “DEPOSITARY”) OR A NOMINEE OF THE DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED
IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY
NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE

 

    Ex-A-2

     

    

DEPOSITARY TO A
NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY
OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH A SUCCESSOR DEPOSITARY.

 

Unless
this certificate is presented by an authorized representative of The DeposiTAry, to the Company or its agent for registration of transfer,
exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by
an authorized representative of the depositAry (and any payment is made to Cede & Co. or to such other entity as is requested by
an authorized representative of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
inasmuch as the registered owner hereof, Cede & Co., has a beneficial interest herein.

 

    Ex-A-3

     

    

	No. [  ]	$[  ]  
	 	CUSIP No. [144A: 30303M 8B1][RegS:
    U59197 AB6]
	 	ISIN [144A: US30303M8B15 ][RegS:
    USU59197AB66]

 

META PLATFORMS,
INC.

 

3.500% SENIOR
NOTE DUE 2027

 

META PLATFORMS,
INC., a corporation in existence under the laws of the State of Delaware (herein called the “Company,” which term
includes any successor corporation under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay
to Cede & Co. or registered assigns, the principal sum of $[ ] on August 15, 2027 (the “Maturity Date”), and to
pay interest on said principal sum semi-annually on February 15 and August 15, commencing February 15, 2023 (each, an “Interest
Payment Date”), at the rate of 3.500% per annum from August 9, 2022, or from the most recent date in respect of which interest
has been paid or duly provided for, until payment of the principal sum has been made or duly provided for. The interest so payable and
punctually paid or duly provided for on any Interest Payment Date will be paid to the Person in whose name this Note (or one or more
predecessor Securities) is registered at the close of business on the record date for such Interest Payment Date, which shall be the
February 1 and August 1 (whether or not a Business Day (as defined below)) next preceding such Interest Payment Date. If the Company
defaults in a payment of any such interest, it shall pay the defaulted interest, plus, to the extent permitted by law, any interest payable
on the defaulted interest, to the Persons who are Holders on a subsequent special record date. The Company shall fix or cause to be fixed
any such special record date and payment date to the reasonable satisfaction of the Trustee and shall promptly mail or cause to be mailed
or deliver by electronic transmission to each Holder a notice that states the special record date, the payment date and the amount of
defaulted interest to be paid. The Company may pay defaulted interest in any lawful manner.

 

Payment of the principal
of and interest on this Note will be made at the Place of Payment in Dollars as more fully provided in the Indenture.

 

Reference is made
to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect as though fully set forth at
this place. Unless the certificate of authentication hereon has been executed by or on behalf of the Trustee by manual signature, this
Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

 

    Ex-A-4

     

    

IN WITNESS WHEREOF,
the Company has caused this instrument to be duly executed.

 

	Dated:	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

    Ex-A-5

     

    

TRUSTEE’S
CERTIFICATE OF AUTHENTICATION

 

This is one of the
Securities of the Series designated therein referred to in the within-mentioned Indenture.

 

	 	U.S. BANK TRUST COMPANY, NATIONAL
    ASSOCIATION, as Trustee
	 	 
	 	 
	 	By:	         
	 	 	Authorized Signatory
	 	 	 
	 	Dated:	 

 

    Ex-A-6

     

    

[FORM OF REVERSE
OF NOTE]

 

META PLATFORMS,
INC.

 

3.500% SENIOR
NOTE DUE 2027

 

This Note is one
of a duly authorized issue of debentures, notes or other debt instruments of the Company (herein called the “Securities”),
issued and to be issued in one or more Series under an Indenture dated as of August 9, 2022 (the “Base Indenture”),
as supplemented by the First Supplemental Indenture dated as of August 9, 2022 (the “First Supplemental Indenture”
and, together with the Base Indenture, the “Indenture”), between the Company and U.S. Bank Trust Company, National
Association, as Trustee (herein called the “Trustee”, which term includes any successor Trustee under the Indenture),
to which Indenture and any other supplemental indenture thereto reference is hereby made for a statement of the respective rights thereunder
of the Company, the Trustee, and the Holders of the Securities, the terms upon which the Securities are, and are to be, authenticated
and delivered, and the definition of capitalized terms used herein and not otherwise defined herein. The Securities may be issued in
one or more Series, which different Series may be issued in various aggregate principal amounts, may be denominated in different currencies,
may mature at different times, may bear interest (if any) at different rates (which rates may be fixed or variable), may be subject to
different redemption provisions (if any), may be subject to different sinking, purchase, or analogous funds (if any), may be subject
to different covenants and Events of Default, and may otherwise vary as provided in the Indenture. This Note is one of a Series of Securities
of the Company designated as set forth on the face hereof (herein called the “2027 Notes”), initially limited in aggregate
principal amount to $2,750,000,000.

 

Interest on the
2027 Notes will be payable semi-annually in arrears on each Interest Payment Date. If any Interest Payment Date, the Maturity Date or
any earlier repayment date falls on a day that is not a Business Day, then payment of interest and/or principal that would otherwise
be payable on such date will be made on the next succeeding Business Day. No interest will accrue on the amount so payable for the period
from such Interest Payment Date, Maturity Date or earlier repayment date, as the case may be, to the date payment is made. Interest on
the 2027 Notes will be paid on the basis of a 360-day year consisting of twelve 30-day months.

 

The Company may
redeem the 2027 Notes, at its option, in whole or in part, at any time and from time to time prior to July 15, 2027 (one month prior
to the maturity date of the 2027 Notes) (the “2027 Par Call Date”), in principal amounts of $1,000 and integral multiples
of $1,000 in excess thereof, provided that the unredeemed portion of a 2027 Note must be in a minimum principal amount of $2,000, for
a redemption price equal to the greater of:

 

(i) the
sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
the 2027 Notes matured on the 2027 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months)
at the Treasury Rate plus 15 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii) 100%
of the principal amount of the 2027 Notes to be redeemed,

 

    Ex-A-7

     

    

plus, in each case, accrued
and unpaid interest to, but excluding, the Redemption Date.

 

The Company may
redeem the 2027 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2027 Par Call Date, in principal
amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2027 Note must be in
a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2027 Notes being redeemed plus
accrued and unpaid interest to the Redemption Date.

 

The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company
and the rights of the Holders of the Securities of each Series under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of at least a majority in aggregate principal amount of the outstanding Securities of each Series to be affected
by such amendment or modification. The Indenture also contains provisions permitting the Holders of at least a majority in principal
amount of the outstanding Securities of each Series to be affected by such waiver, on behalf of the Holders of Securities of such Series,
to waive compliance by the Company with certain provisions of the Indenture or the Securities with respect to such Series. Once effective,
any such consent or waiver by the Holder of this 2027 Note shall be conclusive and binding upon such Holder and upon all future Holders
of this 2027 Note and of any 2027 Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this 2027 Note.

 

The Indenture contains
provisions setting forth certain conditions to the institution of proceedings by Holders of Securities with respect to the Indenture
or for any remedy under the Indenture.

 

If an Event of Default
with respect to the 2027 Notes occurs and is continuing, the principal amount hereof may become immediately due and payable in the manner
and with the effect provided in the Indenture.

 

No reference herein
to the Indenture and no provision of this 2027 Note or of the Indenture shall alter or impair the obligation of the Company, which is
absolute and unconditional, to pay the principal of and interest on this 2027 Note at the times, place and rate, and in the coin or currency,
herein prescribed.

 

As provided in the
Indenture and subject to certain limitations therein set forth, the transfer of this 2027 Note is registerable in the Security register,
upon surrender of this 2027 Note for registration of transfer at the office or agency of the Company duly endorsed, or accompanied by
a written instrument or instruments of transfer in form satisfactory to the Company duly executed, by the Holder hereof or his attorney
duly authorized in writing, and thereupon the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the
designated transferee or transferees, one or more new 2027 Notes of the same Series of any authorized denominations and of a like aggregate
principal amount and bearing such restrictive legends as may be required by the Indenture.

 

The 2027 Notes are
issuable only in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. As provided
in the Indenture and subject to certain limitations therein set forth, this 2027 Note may be exchanged for other

 

    Ex-A-8

     

    

Securities of the
same Series of any authorized denominations and of a like aggregate principal amount, upon surrender of this 2027 Note at the office
or agency of the Company.

 

No service charge
shall be made for any such registration or transfer or exchange, but the Company or the Trustee may require payment of a sum sufficient
to cover any tax, assessment or other governmental charge that may be imposed in connection therewith.

 

Prior to the presentment
of this 2027 Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may deem and treat
the Person in whose name this 2027 Note is registered on the Security register as the absolute owner hereof for the purpose of receiving
payment as herein provided and for all other purposes, whether or not this 2027 Note is overdue, and neither the Company, the Trustee,
nor any agent of the Company or the Trustee shall be affected by notice to the contrary.

 

The Company may,
without the consent of the existing holders of the 2027 Notes, issue additional 2027 Notes of this Series having the same terms (except
the issue date, the date from which interest accrues and, in some cases, the first interest payment date) so that existing 2027 Notes
and additional 2027 Notes form the same series under the Indenture, provided, however, that if any such additional 2027 Notes are not
fungible with the existing 2027 Notes for U.S. federal income tax purposes, such additional 2027 Notes will have a separate CUSIP number.

 

This 2027 Note shall
be governed by and interpreted in accordance with the laws of the State of New York.

 

All terms used in
this 2027 Note which are defined in the Indenture and are not otherwise defined herein shall have the meanings assigned to them in the
Indenture.

 

    Ex-A-9

     

    

[FORM OF TRANSFER
NOTICE]

 

FOR VALUE RECEIVED,
the undersigned hereby sell(s), assign(s) and transfer(s) unto

 

 

 

[PLEASE INSERT SOCIAL SECURITY
OR OTHER IDENTIFYING NUMBER OF ASSIGNEE]

 

 

 

 

 

 

[PLEASE PRINT OR TYPE NAME AND
ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE]

 

the within Note and all rights thereunder,
hereby irrevocably constituting and appointing _________________________ attorney to transfer such Note on the books of the Company,
with full power of substitution in the premises.

 

Dated: _______________________

 

NOTICE: The signature to this assignment
must correspond with the name as written upon the face of the within Note in every particular without alteration or enlargement or any
change whatsoever.

 

    Ex-A-10

     

    

[THE FOLLOWING PROVISION TO BE INCLUDED
ON ALL CERTIFICATES BEARING A RESTRICTED LEGEND]

 

In connection with
any transfer of this Note occurring prior to ____________________, the undersigned confirms that such transfer is made without utilizing
any general solicitation or general advertising and further as follows:

 

Check One

 

	☐(1)
    This Note is being transferred to a “qualified institutional buyer” in compliance with Rule 144A under the Securities
    Act of 1933, as amended and certification in the form of Exhibit G to the Indenture is being furnished herewith.
	☐ (2)
    This Note is being transferred to a Non-U.S. Person in compliance with the exemption from registration under the Securities Act of
    1933, as amended, provided by Regulation S thereunder, and certification in the form of Exhibit F to the Indenture is being furnished
    herewith.
	or
	☐(3)
    This Note is being transferred other than in accordance with (1) or (2) above and documents are being furnished which comply with
    the conditions of transfer set forth in this Note and the Indenture.

If none of the foregoing
boxes is checked, the Trustee is not obligated to register this Note in the name of any Person other than the Holder hereof unless and
until the conditions to any such transfer of registration set forth herein and in the Indenture have been satisfied.

 

Date: _________________

 

	 	 
	 	Seller

 

 

	 	By:	 

 

NOTICE: The signature to this
assignment must correspond with the name as written upon the face of the within-mentioned instrument in every particular, without alteration
or any change whatsoever.

 

    Ex-A-11

     

    

	Signature Guarantee:1	 	 
	 	By:

    
	 
	 	 	To be executed by an executive officer

    

 

 

 

 

1 Signatures must be guaranteed by an
“eligible guarantor institution” meeting the requirements of the Trustee, which requirements include membership or
participation in the Securities Transfer Association Medallion Program (“STAMP”) or such other “signature
guarantee program” as may be determined by the Trustee in addition to, or in substitution for, STAMP, all in accordance with
the Securities Exchange Act of 1934, as amended.

 

    Ex-A-12

     

    

SCHEDULE
OF EXCHANGES OF NOTES

 

The following increases or decreases
of this Global Note have been made:

 

	Date
    of Exchange

    	Amount
    of decrease in principal amount of this Global Note

    	Amount
    of increase in principal amount of this Global Note

    	Principal
amount of this Global Note following such decrease (or increase)
	Signature
of authorized officer of Trustee

	 	 	 	 	 

 

    Ex-A-13

     

    

EXHIBIT B

 

FORM

 

OF

 

3.850% SENIOR NOTE
DUE 2032

 

    Ex-B-1

     

    

[FORM OF FACE OF
NOTE]

 

THE SECURITY (OR ITS PREDECESSOR) EVIDENCED
HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE
ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THE SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED
THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.
THE HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT OF THE ISSUER THAT:

 

		(A)	SUCH SECURITY MAY BE OFFERED, RESOLD,
                                            PLEDGED OR OTHERWISE TRANSFERRED, ONLY:

 

		(i)	(a) TO A PERSON WHO THE SELLER REASONABLY
                                            BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES
                                            ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (b)
                                            IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES ACT, (c) OUTSIDE
                                            THE UNITED STATES TO A NON-U.S. PERSON IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE
                                            903 OR 904 UNDER THE SECURITIES ACT OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE
                                            REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL AND
                                            OTHER CERTIFICATIONS AND DOCUMENTS IF THE ISSUER SO REQUESTS);

 

		(ii)	TO THE ISSUER; OR

 

		(iii)	PURSUANT TO AN EFFECTIVE REGISTRATION
                                            STATEMENT

 

AND, IN EACH CASE, IN ACCORDANCE WITH
ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND IN EACH CASE SUBJECT TO ANY
REQUIREMENT OF LAW THAT THE DISPOSITION OF THIS SECURITY BY THE HOLDER OR BY ANY INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN
ITS OR THEIR CONTROL.

 

THIS SECURITY IS
A REGISTERED GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
TRUST COMPANY (THE “DEPOSITARY”) OR A NOMINEE OF THE DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED
IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY
NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE

 

    Ex-B-2

     

    

DEPOSITARY TO THE
DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
A SUCCESSOR DEPOSITARY.

 

Unless
this certificate is presented by an authorized representative of The DeposiTAry, to the Company or its agent for registration of transfer,
exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by
an authorized representative of the depositAry (and any payment is made to Cede & Co. or to such other entity as is requested by
an authorized representative of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
inasmuch as the registered owner hereof, Cede & Co., has a beneficial interest herein.

 

    Ex-B-3

     

    

	No. [  ]
    	$[  ]  
	 	CUSIP No. [144A: 30303M 8D7][RegS:
    U59197 AD2]
	 	ISIN [144A: US30303M8D70][RegS:
    USU59197AD23]

 

META PLATFORMS,
INC.

 

3.850% SENIOR
NOTE DUE 2032

 

META PLATFORMS,
INC., a corporation in existence under the laws of the State of Delaware (herein called the “Company,” which term
includes any successor corporation under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay
to Cede & Co. or registered assigns, the principal sum of $[ ] on August 15, 2032 (the “Maturity Date”), and to
pay interest on said principal sum semi-annually on February 15 and August 15, commencing February 15, 2023 (each, an “Interest
Payment Date”), at the rate of 3.850% per annum from August 9, 2022, or from the most recent date in respect of which interest
has been paid or duly provided for, until payment of the principal sum has been made or duly provided for. The interest so payable and
punctually paid or duly provided for on any Interest Payment Date will be paid to the Person in whose name this Note (or one or more
predecessor Securities) is registered at the close of business on the record date for such Interest Payment Date, which shall be the
February 1 and August 1 (whether or not a Business Day (as defined below)) next preceding such Interest Payment Date. If the Company
defaults in a payment of any such interest, it shall pay the defaulted interest, plus, to the extent permitted by law, any interest payable
on the defaulted interest, to the Persons who are Holders on a subsequent special record date. The Company shall fix or cause to be fixed
any such special record date and payment date to the reasonable satisfaction of the Trustee and shall promptly mail or cause to be mailed
or deliver by electronic transmission to each Holder a notice that states the special record date, the payment date and the amount of
defaulted interest to be paid. The Company may pay defaulted interest in any lawful manner.

 

Payment of the principal
of and interest on this Note will be made at the Place of Payment in Dollars as more fully provided in the Indenture.

 

Reference is made
to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect as though fully set forth at
this place. Unless the certificate of authentication hereon has been executed by or on behalf of the Trustee by manual signature, this
Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

 

    Ex-B-4

     

    

IN WITNESS WHEREOF,
the Company has caused this instrument to be duly executed.

 

	Dated:	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

    Ex-B-5

     

    

TRUSTEE’S
CERTIFICATE OF AUTHENTICATION

 

This is one of the
Securities of the Series designated therein referred to in the within-mentioned Indenture.

 

	 	U.S. BANK TRUST COMPANY, NATIONAL
    ASSOCIATION, as Trustee
	 	 
	 	 
	 	By:	 
	 	 	Authorized Signatory
	 	 	 
	 	Dated:	 

 

    Ex-B-6

     

    

[FORM OF REVERSE
OF NOTE]

 

META PLATFORMS,
INC.

 

3.850% SENIOR
NOTE DUE 2032

 

This Note is one
of a duly authorized issue of debentures, notes or other debt instruments of the Company (herein called the “Securities”),
issued and to be issued in one or more Series under an Indenture dated as of August 9, 2022 (the “Base Indenture”),
as supplemented by the First Supplemental Indenture dated as of August 9, 2022 (the “First Supplemental Indenture”
and, together with the Base Indenture, the “Indenture”), between the Company and U.S. Bank Trust Company, National
Association, as Trustee (herein called the “Trustee”, which term includes any successor Trustee under the Indenture),
to which Indenture and any other supplemental indenture thereto reference is hereby made for a statement of the respective rights thereunder
of the Company, the Trustee, and the Holders of the Securities, the terms upon which the Securities are, and are to be, authenticated
and delivered, and the definition of capitalized terms used herein and not otherwise defined herein. The Securities may be issued in
one or more Series, which different Series may be issued in various aggregate principal amounts, may be denominated in different currencies,
may mature at different times, may bear interest (if any) at different rates (which rates may be fixed or variable), may be subject to
different redemption provisions (if any), may be subject to different sinking, purchase, or analogous funds (if any), may be subject
to different covenants and Events of Default, and may otherwise vary as provided in the Indenture. This Note is one of a Series of Securities
of the Company designated as set forth on the face hereof (herein called the “2032 Notes”), initially limited in aggregate
principal amount to $3,000,000,000.

 

Interest on the
2032 Notes will be payable semi-annually in arrears on each Interest Payment Date. If any Interest Payment Date, the Maturity Date or
any earlier repayment date falls on a day that is not a Business Day, then payment of interest and/or principal that would otherwise
be payable on such date will be made on the next succeeding Business Day. No interest will accrue on the amount so payable for the period
from such Interest Payment Date, Maturity Date or earlier repayment date, as the case may be, to the date payment is made. Interest on
the 2032 Notes will be paid on the basis of a 360-day year consisting of twelve 30-day months.

 

The Company may
redeem the 2032 Notes, at its option, in whole or in part, at any time and from time to time prior to May 15, 2032 (three months prior
to the maturity date of the 2032 Notes) (the “2032 Par Call Date”), in principal amounts of $1,000 and integral multiples
of $1,000 in excess thereof, provided that the unredeemed portion of a 2032 Note must be in a minimum principal amount of $2,000, for
a redemption price equal to the greater of:

 

(i) the
sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
the 2032 Notes matured on the 2032 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months)
at the Treasury Rate plus 20 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii) 100%
of the principal amount of the 2032 Notes to be redeemed,

 

    Ex-B-7

     

    

plus, in each case, accrued
and unpaid interest to, but excluding, the Redemption Date.

 

The Company may
redeem the 2032 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2032 Par Call Date, in principal
amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2032 Note must be in
a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2032 Notes being redeemed plus
accrued and unpaid interest to the Redemption Date.

 

The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company
and the rights of the Holders of the Securities of each Series under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of at least a majority in aggregate principal amount of the outstanding Securities of each Series to be affected
by such amendment or modification. The Indenture also contains provisions permitting the Holders of at least a majority in principal
amount of the outstanding Securities of each Series to be affected by such waiver, on behalf of the Holders of Securities of such Series,
to waive compliance by the Company with certain provisions of the Indenture or the Securities with respect to such Series. Once effective,
any such consent or waiver by the Holder of this 2032 Note shall be conclusive and binding upon such Holder and upon all future Holders
of this 2032 Note and of any 2032 Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this 2032 Note.

 

The Indenture contains
provisions setting forth certain conditions to the institution of proceedings by Holders of Securities with respect to the Indenture
or for any remedy under the Indenture.

 

If an Event of Default
with respect to the 2032 Notes occurs and is continuing, the principal amount hereof may become immediately due and payable in the manner
and with the effect provided in the Indenture.

 

No reference herein
to the Indenture and no provision of this 2032 Note or of the Indenture shall alter or impair the obligation of the Company, which is
absolute and unconditional, to pay the principal of and interest on this 2032 Note at the times, place and rate, and in the coin or currency,
herein prescribed.

 

As provided in the
Indenture and subject to certain limitations therein set forth, the transfer of this 2032 Note is registerable in the Security register,
upon surrender of this 2032 Note for registration of transfer at the office or agency of the Company duly endorsed, or accompanied by
a written instrument or instruments of transfer in form satisfactory to the Company duly executed, by the Holder hereof or his attorney
duly authorized in writing, and thereupon the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the
designated transferee or transferees, one or more new 2032 Notes of the same Series of any authorized denominations and of a like aggregate
principal amount and bearing such restrictive legends as may be required by the Indenture.

 

The 2032 Notes are
issuable only in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. As provided
in the Indenture and subject to certain limitations therein set forth, this 2032 Note may be exchanged for other

 

    Ex-B-8

     

    

Securities of the
same Series of any authorized denominations and of a like aggregate principal amount, upon surrender of this 2032 Note at the office
or agency of the Company.

 

No service charge
shall be made for any such registration or transfer or exchange, but the Company or the Trustee may require payment of a sum sufficient
to cover any tax, assessment or other governmental charge that may be imposed in connection therewith.

 

Prior to the presentment
of this 2032 Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may deem and treat
the Person in whose name this 2032 Note is registered on the Security register as the absolute owner hereof for the purpose of receiving
payment as herein provided and for all other purposes, whether or not this 2032 Note is overdue, and neither the Company, the Trustee,
nor any agent of the Company or the Trustee shall be affected by notice to the contrary.

 

The Company may,
without the consent of the existing holders of the 2032 Notes, issue additional 2032 Notes of this Series having the same terms (except
the issue date, the date from which interest accrues and, in some cases, the first interest payment date) so that existing 2032 Notes
and additional 2032 Notes form the same series under the Indenture, provided, however, that if any such additional 2032 Notes are not
fungible with the existing 2032 Notes for U.S. federal income tax purposes, such additional 2032 Notes will have a separate CUSIP number.

 

This 2032 Note shall
be governed by and interpreted in accordance with the laws of the State of New York.

 

All terms used in
this 2032 Note which are defined in the Indenture and are not otherwise defined herein shall have the meanings assigned to them in the
Indenture.

 

    Ex-B-9

     

    

[FORM OF TRANSFER
NOTICE]

 

FOR VALUE RECEIVED,
the undersigned hereby sell(s), assign(s) and transfer(s) unto

 

 

 

[PLEASE INSERT SOCIAL SECURITY
OR OTHER IDENTIFYING NUMBER OF ASSIGNEE]

 

 

 

 

 

 

[PLEASE PRINT OR TYPE NAME AND
ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE]

 

the within Note and all rights thereunder,
hereby irrevocably constituting and appointing _________________________ attorney to transfer such Note on the books of the Company,
with full power of substitution in the premises.

 

Dated: _______________________

 

NOTICE: The signature to this assignment
must correspond with the name as written upon the face of the within Note in every particular without alteration or enlargement or any
change whatsoever.

 

    Ex-B-10

     

    

[THE FOLLOWING PROVISION TO BE INCLUDED
ON ALL CERTIFICATES BEARING A RESTRICTED LEGEND]

 

In connection with
any transfer of this Note occurring prior to ____________________, the undersigned confirms that such transfer is made without utilizing
any general solicitation or general advertising and further as follows:

 

Check One

 

	☐(1)
    This Note is being transferred to a “qualified institutional buyer” in compliance with Rule 144A under the Securities
    Act of 1933, as amended and certification in the form of Exhibit G to the Indenture is being furnished herewith.
	☐ (2)
    This Note is being transferred to a Non-U.S. Person in compliance with the exemption from registration under the Securities Act of
    1933, as amended, provided by Regulation S thereunder, and certification in the form of Exhibit F to the Indenture is being furnished
    herewith.
	or
	☐(3)
    This Note is being transferred other than in accordance with (1) or (2) above and documents are being furnished which comply with
    the conditions of transfer set forth in this Note and the Indenture.

If none of the foregoing
boxes is checked, the Trustee is not obligated to register this Note in the name of any Person other than the Holder hereof unless and
until the conditions to any such transfer of registration set forth herein and in the Indenture have been satisfied.

 

Date: _________________

 

	 	 
	 	Seller

 

 

	 	By:	 

 

NOTICE: The signature to this
assignment must correspond with the name as written upon the face of the within-mentioned instrument in every particular, without alteration
or any change whatsoever.

 

    Ex-B-11

     

    

	Signature Guarantee:2	 	 
	 	By:

    
	 
	 	 	To be executed by an executive officer

    

 

 

 

2 Signatures must be guaranteed by an
“eligible guarantor institution” meeting the requirements of the Trustee, which requirements include membership or
participation in the Securities Transfer Association Medallion Program (“STAMP”) or such other “signature
guarantee program” as may be determined by the Trustee in addition to, or in substitution for, STAMP, all in accordance with
the Securities Exchange Act of 1934, as amended.

    Ex-B-12

     

    

SCHEDULE
OF EXCHANGES OF NOTES

 

The following increases or decreases
of this Global Note have been made:

 

	Date
    of Exchange

    	Amount
    of decrease in principal amount of this Global Note

    	Amount
    of increase in principal amount of this Global Note

    	Principal
    amount of this Global Note following such decrease (or increase)

    	Signature
    of authorized officer of Trustee

    
	 	 	 	 	 

 

    Ex-B-13

     

    

Exhibit C

 

FORM

 

OF

 

4.450% SENIOR NOTE
DUE 2052

 

    Ex-C-1

     

    

[FORM OF FACE OF
NOTE]

 

THE SECURITY (OR ITS PREDECESSOR) EVIDENCED
HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE
ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THE SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED
THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.
THE HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT OF THE ISSUER THAT:

 

		(A)	SUCH SECURITY MAY BE OFFERED, RESOLD,
                                            PLEDGED OR OTHERWISE TRANSFERRED, ONLY:

 

		(i)	(a) TO A PERSON WHO THE SELLER REASONABLY
                                            BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES
                                            ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (b)
                                            IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES ACT, (c) OUTSIDE
                                            THE UNITED STATES TO A NON-U.S. PERSON IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE
                                            903 OR 904 UNDER THE SECURITIES ACT OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE
                                            REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL AND
                                            OTHER CERTIFICATIONS AND DOCUMENTS IF THE ISSUER SO REQUESTS);

 

		(ii)	TO THE ISSUER; OR

 

		(iii)	PURSUANT TO AN EFFECTIVE REGISTRATION
                                            STATEMENT

 

AND, IN EACH CASE, IN ACCORDANCE WITH
ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND IN EACH CASE SUBJECT TO ANY
REQUIREMENT OF LAW THAT THE DISPOSITION OF THIS SECURITY BY THE HOLDER OR BY ANY INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN
ITS OR THEIR CONTROL.

 

THIS SECURITY IS
A REGISTERED GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
TRUST COMPANY (THE “DEPOSITARY”) OR A NOMINEE OF THE DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED
IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY
NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE

 

    Ex-C-2

     

    

DEPOSITARY TO THE
DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
A SUCCESSOR DEPOSITARY.

 

Unless
this certificate is presented by an authorized representative of The DeposiTAry, to the Company or its agent for registration of transfer,
exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by
an authorized representative of the depositAry (and any payment is made to Cede & Co. or to such other entity as is requested by
an authorized representative of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
inasmuch as the registered owner hereof, Cede & Co., has a beneficial interest herein.

 

    Ex-C-3

     

    

	No. [  ]	$[  ]  
	 	CUSIP No. [144A: 30303M 8E5][RegS:
    U59197 AE0]
	 	ISIN [144A: US30303M8E53][RegS:
    USU59197AE06]

META PLATFORMS,
INC.

 

4.450% SENIOR
NOTE DUE 2052

 

META PLATFORMS,
INC., a corporation in existence under the laws of the State of Delaware (herein called the “Company,” which term
includes any successor corporation under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay
to Cede & Co. or registered assigns, the principal sum of $[ ] on August 15, 2052 (the “Maturity Date”), and to
pay interest on said principal sum semi-annually on February 15 and August 15, commencing February 15, 2023 (each, an “Interest
Payment Date”), at the rate of 4.450% per annum from August 9, 2022, or from the most recent date in respect of which interest
has been paid or duly provided for, until payment of the principal sum has been made or duly provided for. The interest so payable and
punctually paid or duly provided for on any Interest Payment Date will be paid to the Person in whose name this Note (or one or more
predecessor Securities) is registered at the close of business on the record date for such Interest Payment Date, which shall be the
February 1 and August 1 (whether or not a Business Day (as defined below)) next preceding such Interest Payment Date. If the Company
defaults in a payment of any such interest, it shall pay the defaulted interest, plus, to the extent permitted by law, any interest payable
on the defaulted interest, to the Persons who are Holders on a subsequent special record date. The Company shall fix or cause to be fixed
any such special record date and payment date to the reasonable satisfaction of the Trustee and shall promptly mail or cause to be mailed
or deliver by electronic transmission to each Holder a notice that states the special record date, the payment date and the amount of
defaulted interest to be paid. The Company may pay defaulted interest in any lawful manner.

 

Payment of the principal
of and interest on this Note will be made at the Place of Payment in Dollars as more fully provided in the Indenture.

 

Reference is made
to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect as though fully set forth at
this place. Unless the certificate of authentication hereon has been executed by or on behalf of the Trustee by manual signature, this
Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

 

    Ex-C-4

     

    

IN WITNESS WHEREOF,
the Company has caused this instrument to be duly executed.

 

	Dated:	By:	 
	 	 	Name:
	 	 	Title:

 

    Ex-C-5

     

    

TRUSTEE’S
CERTIFICATE OF AUTHENTICATION

 

This is one of the
Securities of the Series designated therein referred to in the within-mentioned Indenture.

 

	 	U.S. BANK TRUST COMPANY, NATIONAL
    ASSOCIATION, as Trustee
	 	 
	 	 
	 	By:	 
	 	 	Authorized Signatory
	 	 	 
	 	Dated:	 

 

    Ex-C-6

     

    

[FORM OF REVERSE
OF NOTE]

 

META PLATFORMS,
INC.

 

4.450% SENIOR
NOTE DUE 2052

 

This Note is one
of a duly authorized issue of debentures, notes or other debt instruments of the Company (herein called the “Securities”),
issued and to be issued in one or more Series under an Indenture dated as of August 9, 2022 (the “Base Indenture”),
as supplemented by the First Supplemental Indenture dated as of August 9, 2022 (the “First Supplemental Indenture”
and, together with the Base Indenture, the “Indenture”), between the Company and U.S. Bank Trust Company, National
Association, as Trustee (herein called the “Trustee”, which term includes any successor Trustee under the Indenture),
to which Indenture and any other supplemental indenture thereto reference is hereby made for a statement of the respective rights thereunder
of the Company, the Trustee, and the Holders of the Securities, the terms upon which the Securities are, and are to be, authenticated
and delivered, and the definition of capitalized terms used herein and not otherwise defined herein. The Securities may be issued in
one or more Series, which different Series may be issued in various aggregate principal amounts, may be denominated in different currencies,
may mature at different times, may bear interest (if any) at different rates (which rates may be fixed or variable), may be subject to
different redemption provisions (if any), may be subject to different sinking, purchase, or analogous funds (if any), may be subject
to different covenants and Events of Default, and may otherwise vary as provided in the Indenture. This Note is one of a Series of Securities
of the Company designated as set forth on the face hereof (herein called the “2052 Notes”), initially limited in aggregate
principal amount to $2,750,000,000.

 

Interest on the
2052 Notes will be payable semi-annually in arrears on each Interest Payment Date. If any Interest Payment Date, the Maturity Date or
any earlier repayment date falls on a day that is not a Business Day, then payment of interest and/or principal that would otherwise
be payable on such date will be made on the next succeeding Business Day. No interest will accrue on the amount so payable for the period
from such Interest Payment Date, Maturity Date or earlier repayment date, as the case may be, to the date payment is made. Interest on
the 2052 Notes will be paid on the basis of a 360-day year consisting of twelve 30-day months.

 

The Company may
redeem the 2052 Notes, at its option, in whole or in part, at any time and from time to time prior to February 15, 2052 (six months prior
to the maturity date of the 2052 Notes) (the “2052 Par Call Date”), in principal amounts of $1,000 and integral multiples
of $1,000 in excess thereof, provided that the unredeemed portion of a 2052 Note must be in a minimum principal amount of $2,000, for
a redemption price equal to the greater of:

 

(i) the
sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
the 2052 Notes matured on the 2052 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months)
at the Treasury Rate plus 25 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii) 100%
of the principal amount of the 2052 Notes to be redeemed,

 

    Ex-C-7

     

    

plus, in each case, accrued
and unpaid interest to, but excluding, the Redemption Date.

 

The Company may
redeem the 2052 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2052 Par Call Date, in principal
amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2052 Note must be in
a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2052 Notes being redeemed plus
accrued and unpaid interest to the Redemption Date.

 

The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company
and the rights of the Holders of the Securities of each Series under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of at least a majority in aggregate principal amount of the outstanding Securities of each Series to be affected
by such amendment or modification. The Indenture also contains provisions permitting the Holders of at least a majority in principal
amount of the outstanding Securities of each Series to be affected by such waiver, on behalf of the Holders of Securities of such Series,
to waive compliance by the Company with certain provisions of the Indenture or the Securities with respect to such Series. Once effective,
any such consent or waiver by the Holder of this 2052 Note shall be conclusive and binding upon such Holder and upon all future Holders
of this 2052 Note and of any 2052 Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this 2052 Note.

 

The Indenture contains
provisions setting forth certain conditions to the institution of proceedings by Holders of Securities with respect to the Indenture
or for any remedy under the Indenture.

 

If an Event of Default
with respect to the 2052 Notes occurs and is continuing, the principal amount hereof may become immediately due and payable in the manner
and with the effect provided in the Indenture.

 

No reference herein
to the Indenture and no provision of this 2052 Note or of the Indenture shall alter or impair the obligation of the Company, which is
absolute and unconditional, to pay the principal of and interest on this 2052 Note at the times, place and rate, and in the coin or currency,
herein prescribed.

 

As provided in the
Indenture and subject to certain limitations therein set forth, the transfer of this 2052 Note is registerable in the Security register,
upon surrender of this 2052 Note for registration of transfer at the office or agency of the Company duly endorsed, or accompanied by
a written instrument or instruments of transfer in form satisfactory to the Company duly executed, by the Holder hereof or his attorney
duly authorized in writing, and thereupon the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the
designated transferee or transferees, one or more new 2052 Notes of the same Series of any authorized denominations and of a like aggregate
principal amount and bearing such restrictive legends as may be required by the Indenture.

 

The 2052 Notes are
issuable only in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. As provided
in the Indenture and subject to certain limitations therein set forth, this 2052 Note may be exchanged for other

 

    Ex-C-8

     

    

Securities of the
same Series of any authorized denominations and of a like aggregate principal amount, upon surrender of this 2052 Note at the office
or agency of the Company.

 

No service charge
shall be made for any such registration or transfer or exchange, but the Company or the Trustee may require payment of a sum sufficient
to cover any tax, assessment or other governmental charge that may be imposed in connection therewith.

 

Prior to the presentment
of this 2052 Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may deem and treat
the Person in whose name this 2052 Note is registered on the Security register as the absolute owner hereof for the purpose of receiving
payment as herein provided and for all other purposes, whether or not this 2052 Note is overdue, and neither the Company, the Trustee,
nor any agent of the Company or the Trustee shall be affected by notice to the contrary.

 

The Company may,
without the consent of the existing holders of the 2052 Notes, issue additional 2052 Notes of this Series having the same terms (except
the issue date, the date from which interest accrues and, in some cases, the first interest payment date) so that existing 2052 Notes
and additional 2052 Notes form the same series under the Indenture, provided, however, that if any such additional 2052 Notes are not
fungible with the existing 2052 Notes for U.S. federal income tax purposes, such additional 2052 Notes will have a separate CUSIP number.

 

This 2052 Note shall
be governed by and interpreted in accordance with the laws of the State of New York.

 

All terms used in
this 2052 Note which are defined in the Indenture and are not otherwise defined herein shall have the meanings assigned to them in the
Indenture.

 

    Ex-C-9

     

    

[FORM OF TRANSFER
NOTICE]

 

FOR VALUE RECEIVED,
the undersigned hereby sell(s), assign(s) and transfer(s) unto

 

 

 

[PLEASE INSERT SOCIAL SECURITY
OR OTHER IDENTIFYING NUMBER OF ASSIGNEE]

 

 

 

 

 

 

[PLEASE PRINT OR TYPE NAME AND
ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE]

 

the within Note and all rights thereunder,
hereby irrevocably constituting and appointing _________________________ attorney to transfer such Note on the books of the Company,
with full power of substitution in the premises.

 

Dated: _______________________

 

NOTICE: The signature to this assignment
must correspond with the name as written upon the face of the within Note in every particular without alteration or enlargement or any
change whatsoever.

 

    Ex-C-10

     

    

[THE FOLLOWING PROVISION TO BE INCLUDED
ON ALL CERTIFICATES BEARING A RESTRICTED LEGEND]

 

In connection with
any transfer of this Note occurring prior to ____________________, the undersigned confirms that such transfer is made without utilizing
any general solicitation or general advertising and further as follows:

 

Check One

 

	☐(1)
    This Note is being transferred to a “qualified institutional buyer” in compliance with Rule 144A under the Securities
    Act of 1933, as amended and certification in the form of Exhibit G to the Indenture is being furnished herewith.
	☐ (2)
    This Note is being transferred to a Non-U.S. Person in compliance with the exemption from registration under the Securities Act of
    1933, as amended, provided by Regulation S thereunder, and certification in the form of Exhibit F to the Indenture is being furnished
    herewith.
	or
	☐(3)
    This Note is being transferred other than in accordance with (1) or (2) above and documents are being furnished which comply with
    the conditions of transfer set forth in this Note and the Indenture.

If none of the foregoing
boxes is checked, the Trustee is not obligated to register this Note in the name of any Person other than the Holder hereof unless and
until the conditions to any such transfer of registration set forth herein and in the Indenture have been satisfied.

 

Date: _________________

 

	 	 
	 	Seller

 

 

	 	By:	 

 

NOTICE: The signature to this
assignment must correspond with the name as written upon the face of the within-mentioned instrument in every particular, without alteration
or any change whatsoever.

 

    Ex-C-11

     

    

	Signature Guarantee:3	 	 
	 	By:

    
	 
	 	 	To be executed by an executive officer

    

 

 

 

3 Signatures must be guaranteed by
an “eligible guarantor institution” meeting the requirements of the Trustee, which requirements include membership
or participation in the Securities Transfer Association Medallion Program (“STAMP”) or such other “signature
guarantee program” as may be determined by the Trustee in addition to, or in substitution for, STAMP, all in accordance with
the Securities Exchange Act of 1934, as amended. 

 

    Ex-C-12

     

    

SCHEDULE
OF EXCHANGES OF NOTES

 

The following increases or decreases
of this Global Note have been made:

 

	Date
    of Exchange

    	Amount
    of decrease in principal amount of this Global Note

    	Amount
    of increase in principal amount of this Global Note

    	Principal
    amount of this Global Note following such decrease (or increase)

    	Signature
    of authorized officer of Trustee

    
	 	 	 	 	 

 

    Ex-C-13

     

    

Exhibit D

 

FORM

 

OF

 

4.650% SENIOR NOTE
DUE 2062

 

    Ex-D-1

     

    

[FORM OF FACE OF
NOTE]

 

THE SECURITY (OR ITS PREDECESSOR) EVIDENCED
HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE
ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THE SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED
THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.
THE HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT OF THE ISSUER THAT:

 

		(A)	SUCH SECURITY MAY BE OFFERED, RESOLD,
                                            PLEDGED OR OTHERWISE TRANSFERRED, ONLY:

 

		(i)	(a) TO A PERSON WHO THE SELLER REASONABLY
                                            BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES
                                            ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (b)
                                            IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES ACT, (c) OUTSIDE
                                            THE UNITED STATES TO A NON-U.S. PERSON IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE
                                            903 OR 904 UNDER THE SECURITIES ACT OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE
                                            REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL AND
                                            OTHER CERTIFICATIONS AND DOCUMENTS IF THE ISSUER SO REQUESTS);

 

		(ii)	TO THE ISSUER; OR

 

		(iii)	PURSUANT TO AN EFFECTIVE REGISTRATION
                                            STATEMENT

 

AND, IN EACH CASE, IN ACCORDANCE WITH
ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND IN EACH CASE SUBJECT TO ANY
REQUIREMENT OF LAW THAT THE DISPOSITION OF THIS SECURITY BY THE HOLDER OR BY ANY INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN
ITS OR THEIR CONTROL.

 

THIS SECURITY IS
A REGISTERED GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY
TRUST COMPANY (THE “DEPOSITARY”) OR A NOMINEE OF THE DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED
IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY
NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE

 

    Ex-D-2

     

    

DEPOSITARY TO THE
DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
A SUCCESSOR DEPOSITARY.

 

Unless
this certificate is presented by an authorized representative of The DeposiTAry, to the Company or its agent for registration of transfer,
exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by
an authorized representative of the depositAry (and any payment is made to Cede & Co. or to such other entity as is requested by
an authorized representative of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
inasmuch as the registered owner hereof, Cede & Co., has a beneficial interest herein.

 

    Ex-D-3

     

    

	No. [  ]	$[  ]  
	 	CUSIP No. [144A: 30303M 8F2][RegS:
    U59197 AF7]
	 	ISIN [144A: US30303M8F29][RegS:
    USU59197AF70]

 

META PLATFORMS,
INC.

 

4.650% SENIOR
NOTE DUE 2062

 

META PLATFORMS,
INC., a corporation in existence under the laws of the State of Delaware (herein called the “Company,” which term
includes any successor corporation under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay
to Cede & Co. or registered assigns, the principal sum of $[ ] on August 15, 2062 (the “Maturity Date”), and to
pay interest on said principal sum semi-annually on February 15 and August 15, commencing February 15, 2023 (each, an “Interest
Payment Date”), at the rate of 4.650% per annum from August 9, 2022, or from the most recent date in respect of which interest
has been paid or duly provided for, until payment of the principal sum has been made or duly provided for. The interest so payable and
punctually paid or duly provided for on any Interest Payment Date will be paid to the Person in whose name this Note (or one or more
predecessor Securities) is registered at the close of business on the record date for such Interest Payment Date, which shall be the
February 1 and August 1 (whether or not a Business Day (as defined below)) next preceding such Interest Payment Date. If the Company
defaults in a payment of any such interest, it shall pay the defaulted interest, plus, to the extent permitted by law, any interest payable
on the defaulted interest, to the Persons who are Holders on a subsequent special record date. The Company shall fix or cause to be fixed
any such special record date and payment date to the reasonable satisfaction of the Trustee and shall promptly mail or cause to be mailed
or deliver by electronic transmission to each Holder a notice that states the special record date, the payment date and the amount of
defaulted interest to be paid. The Company may pay defaulted interest in any lawful manner.

 

Payment of the principal
of and interest on this Note will be made at the Place of Payment in Dollars as more fully provided in the Indenture.

 

Reference is made
to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect as though fully set forth at
this place. Unless the certificate of authentication hereon has been executed by or on behalf of the Trustee by manual signature, this
Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

 

    Ex-D-4

     

    

IN WITNESS WHEREOF,
the Company has caused this instrument to be duly executed.

 

	Dated:	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

    Ex-D-5

     

    

TRUSTEE’S
CERTIFICATE OF AUTHENTICATION

 

This is one of the
Securities of the Series designated therein referred to in the within-mentioned Indenture.

 

	 	U.S. BANK TRUST COMPANY, NATIONAL
    ASSOCIATION, as Trustee
	 	 
	 	 
	 	By:	 
	 	 	Authorized Signatory
	 	 	 
	 	Dated:	 

 

    Ex-D-6

     

    

[FORM OF REVERSE
OF NOTE]

 

META PLATFORMS,
INC.

 

4.650% SENIOR
NOTE DUE 2062

 

This Note is one
of a duly authorized issue of debentures, notes or other debt instruments of the Company (herein called the “Securities”),
issued and to be issued in one or more Series under an Indenture dated as of August 9, 2022 (the “Base Indenture”),
as supplemented by the First Supplemental Indenture dated as of August 9, 2022 (the “First Supplemental Indenture”
and, together with the Base Indenture, the “Indenture”), between the Company and U.S. Bank Trust Company, National
Association, as Trustee (herein called the “Trustee”, which term includes any successor Trustee under the Indenture),
to which Indenture and any other supplemental indenture thereto reference is hereby made for a statement of the respective rights thereunder
of the Company, the Trustee, and the Holders of the Securities, the terms upon which the Securities are, and are to be, authenticated
and delivered, and the definition of capitalized terms used herein and not otherwise defined herein. The Securities may be issued in
one or more Series, which different Series may be issued in various aggregate principal amounts, may be denominated in different currencies,
may mature at different times, may bear interest (if any) at different rates (which rates may be fixed or variable), may be subject to
different redemption provisions (if any), may be subject to different sinking, purchase, or analogous funds (if any), may be subject
to different covenants and Events of Default, and may otherwise vary as provided in the Indenture. This Note is one of a Series of Securities
of the Company designated as set forth on the face hereof (herein called the “2062 Notes”), initially limited in aggregate
principal amount to $1,500,000,000.

 

Interest on the
2062 Notes will be payable semi-annually in arrears on each Interest Payment Date. If any Interest Payment Date, the Maturity Date or
any earlier repayment date falls on a day that is not a Business Day, then payment of interest and/or principal that would otherwise
be payable on such date will be made on the next succeeding Business Day. No interest will accrue on the amount so payable for the period
from such Interest Payment Date, Maturity Date or earlier repayment date, as the case may be, to the date payment is made. Interest on
the 2062 Notes will be paid on the basis of a 360-day year consisting of twelve 30-day months.

 

The Company may
redeem the 2062 Notes, at its option, in whole or in part, at any time and from time to time prior to February 15, 2062 (six months prior
to the maturity date of the 2062 Notes) (the “2062 Par Call Date”), in principal amounts of $1,000 and integral multiples
of $1,000 in excess thereof, provided that the unredeemed portion of a 2062 Note must be in a minimum principal amount of $2,000, for
a redemption price equal to the greater of:

 

(i) the
sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
the 2062 Notes matured on the 2062 Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months)
at the Treasury Rate plus 25 basis points, less (b) interest accrued to the Redemption Date, and

 

(ii) 100%
of the principal amount of the 2062 Notes to be redeemed,

 

    Ex-D-7

     

    

plus, in each case, accrued
and unpaid interest to, but excluding, the Redemption Date.

 

The Company may
redeem the 2062 Notes, at its option, in whole or in part, at any time and from time to time on or after the 2062 Par Call Date, in principal
amounts of $1,000 and integral multiples of $1,000 in excess thereof, provided that the unredeemed portion of a 2062 Note must be in
a minimum principal amount of $2,000, at a redemption price equal to 100% of the principal amount of the 2062 Notes being redeemed plus
accrued and unpaid interest to the Redemption Date.

 

The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company
and the rights of the Holders of the Securities of each Series under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of at least a majority in aggregate principal amount of the outstanding Securities of each Series to be affected
by such amendment or modification. The Indenture also contains provisions permitting the Holders of at least a majority in principal
amount of the outstanding Securities of each Series to be affected by such waiver, on behalf of the Holders of Securities of such Series,
to waive compliance by the Company with certain provisions of the Indenture or the Securities with respect to such Series. Once effective,
any such consent or waiver by the Holder of this 2062 Note shall be conclusive and binding upon such Holder and upon all future Holders
of this 2062 Note and of any 2062 Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this 2062 Note.

 

The Indenture contains
provisions setting forth certain conditions to the institution of proceedings by Holders of Securities with respect to the Indenture
or for any remedy under the Indenture.

 

If an Event of Default
with respect to the 2062 Notes occurs and is continuing, the principal amount hereof may become immediately due and payable in the manner
and with the effect provided in the Indenture.

 

No reference herein
to the Indenture and no provision of this 2062 Note or of the Indenture shall alter or impair the obligation of the Company, which is
absolute and unconditional, to pay the principal of and interest on this 2062 Note at the times, place and rate, and in the coin or currency,
herein prescribed.

 

As provided in the
Indenture and subject to certain limitations therein set forth, the transfer of this 2062 Note is registerable in the Security register,
upon surrender of this 2062 Note for registration of transfer at the office or agency of the Company duly endorsed, or accompanied by
a written instrument or instruments of transfer in form satisfactory to the Company duly executed, by the Holder hereof or his attorney
duly authorized in writing, and thereupon the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the
designated transferee or transferees, one or more new 2062 Notes of the same Series of any authorized denominations and of a like aggregate
principal amount and bearing such restrictive legends as may be required by the Indenture.

 

The 2062 Notes are
issuable only in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. As provided
in the Indenture and subject to certain limitations therein set forth, this 2062 Note may be exchanged for other

 

    Ex-D-8

     

    

Securities of the
same Series of any authorized denominations and of a like aggregate principal amount, upon surrender of this 2062 Note at the office
or agency of the Company.

 

No service charge
shall be made for any such registration or transfer or exchange, but the Company or the Trustee may require payment of a sum sufficient
to cover any tax, assessment or other governmental charge that may be imposed in connection therewith.

 

Prior to the presentment
of this 2062 Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may deem and treat
the Person in whose name this 2062 Note is registered on the Security register as the absolute owner hereof for the purpose of receiving
payment as herein provided and for all other purposes, whether or not this 2062 Note is overdue, and neither the Company, the Trustee,
nor any agent of the Company or the Trustee shall be affected by notice to the contrary.

 

The Company may,
without the consent of the existing holders of the 2062 Notes, issue additional 2062 Notes of this Series having the same terms (except
the issue date, the date from which interest accrues and, in some cases, the first interest payment date) so that existing 2062 Notes
and additional 2062 Notes form the same series under the Indenture, provided, however, that if any such additional 2062 Notes are not
fungible with the existing 2062 Notes for U.S. federal income tax purposes, such additional 2062 Notes will have a separate CUSIP number.

 

This 2062 Note shall
be governed by and interpreted in accordance with the laws of the State of New York.

 

All terms used in
this 2062 Note which are defined in the Indenture and are not otherwise defined herein shall have the meanings assigned to them in the
Indenture.

 

    Ex-D-9

     

    

[FORM OF TRANSFER
NOTICE]

 

FOR VALUE RECEIVED,
the undersigned hereby sell(s), assign(s) and transfer(s) unto

 

 

 

[PLEASE INSERT SOCIAL SECURITY
OR OTHER IDENTIFYING NUMBER OF ASSIGNEE]

 

 

 

 

 

 

[PLEASE PRINT OR TYPE NAME AND
ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE]

 

the within Note and all rights thereunder,
hereby irrevocably constituting and appointing _________________________ attorney to transfer such Note on the books of the Company,
with full power of substitution in the premises.

 

Dated: _______________________

 

NOTICE: The signature to this assignment
must correspond with the name as written upon the face of the within Note in every particular without alteration or enlargement or any
change whatsoever.

 

    Ex-D-10

     

    

[THE FOLLOWING PROVISION TO BE INCLUDED
ON ALL CERTIFICATES BEARING A RESTRICTED LEGEND]

 

In connection with
any transfer of this Note occurring prior to ____________________, the undersigned confirms that such transfer is made without utilizing
any general solicitation or general advertising and further as follows:

 

Check One

 

	☐(1)
    This Note is being transferred to a “qualified institutional buyer” in compliance with Rule 144A under the Securities
    Act of 1933, as amended and certification in the form of Exhibit G to the Indenture is being furnished herewith.
	☐ (2)
    This Note is being transferred to a Non-U.S. Person in compliance with the exemption from registration under the Securities Act of
    1933, as amended, provided by Regulation S thereunder, and certification in the form of Exhibit F to the Indenture is being furnished
    herewith.
	or
	☐(3)
    This Note is being transferred other than in accordance with (1) or (2) above and documents are being furnished which comply with
    the conditions of transfer set forth in this Note and the Indenture.

If none of the foregoing
boxes is checked, the Trustee is not obligated to register this Note in the name of any Person other than the Holder hereof unless and
until the conditions to any such transfer of registration set forth herein and in the Indenture have been satisfied.

 

Date: _________________

 

	 	 
	 	Seller

  

 

	 	By:	 

 

NOTICE: The signature to this
assignment must correspond with the name as written upon the face of the within-mentioned instrument in every particular, without alteration
or any change whatsoever.

 

    Ex-D-11

     

    

	Signature Guarantee:4	 	 
	 	By:

    
	 
	 	 	To be executed by an executive officer

    

 

 

 

 

4 Signatures must be guaranteed by an
“eligible guarantor institution” meeting the requirements of the Trustee, which requirements include membership or
participation in the Securities Transfer Association Medallion Program (“STAMP”) or such other “signature
guarantee program” as may be determined by the Trustee in addition to, or in substitution for, STAMP, all in accordance with
the Securities Exchange Act of 1934, as amended.

    Ex-D-12

     

    

SCHEDULE
OF EXCHANGES OF NOTES

 

The following increases or decreases
of this Global Note have been made:

 

	Date
    of Exchange

    	Amount
    of decrease in principal amount of this Global Note

    	Amount
    of increase in principal amount of this Global Note

    	Principal
    amount of this Global Note following such decrease (or increase)

    	Signature
    of authorized officer of Trustee

    
	 	 	 	 	 

 

    Ex-D-13

     

    

Exhibit
E

 

[Restricted
Securities Legend]

 

THE SECURITY (OR ITS PREDECESSOR) EVIDENCED
HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE
ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THE SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED
THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.
THE HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT OF THE ISSUER THAT:

 

		(A)	SUCH SECURITY MAY BE OFFERED, RESOLD,
                                            PLEDGED OR OTHERWISE TRANSFERRED, ONLY:

 

		(i)	(a) TO A PERSON WHO THE SELLER REASONABLY
                                            BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES
                                            ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (b)
                                            IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES ACT, (c) OUTSIDE
                                            THE UNITED STATES TO A NON-U.S. PERSON IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE
                                            903 OR 904 UNDER THE SECURITIES ACT OR (d) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE
                                            REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL AND
                                            OTHER CERTIFICATIONS AND DOCUMENTS IF THE ISSUER SO REQUESTS);

 

		(ii)	TO THE ISSUER; OR

 

		(iii)	PURSUANT TO AN EFFECTIVE REGISTRATION
                                            STATEMENT

 

AND, IN EACH CASE, IN ACCORDANCE WITH
ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND IN EACH CASE SUBJECT TO ANY
REQUIREMENT OF LAW THAT THE DISPOSITION OF THIS SECURITY BY THE HOLDER OR BY ANY INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN
ITS OR THEIR CONTROL.

 

    Ex-E-1

     

    

Exhibit F

 

Regulation S
Certificate

 

		To:	U.S. Bank Trust Company, National Association,
                                            as Trustee (the “Trustee”)

                                            1 California Street, Suite 1000

San Francisco,
CA 94111

Attention:
David Jason (Meta Platforms, Inc.)

 

		Re:	[3.500% Notes due 2027][3.850% Notes due
                                            2032][4.450% Notes due 2052][4.650% Notes due 2062] (the “Notes”) issued
                                            under the Indenture dated as of August 9, 2022 between Meta Platforms, Inc. (the “Company”)
                                            and the Trustee, as supplemented by the First Supplemental Indenture thereto dated as of
                                            August 9, 2022 (together, the “Indenture”)

 

Ladies and Gentlemen:

 

Terms are used in
this Certificate as used in Regulation S (“Regulation S”) under the Securities Act of 1933, as amended (the “Securities
Act”), except as otherwise stated herein.

 

[CHECK A OR B
AS APPLICABLE.]

 

☐A.This Certificate
relates to our proposed transfer of $____ principal amount of Notes issued under the Indenture. We hereby certify as follows:

 

		1.	The offer and sale of the Notes was not
                                            and will not be made to a person in the United States (unless such person is excluded from
                                            the definition of “U.S. person” pursuant to Rule 902(k)(2)(vi) or the
                                            account held by it for which it is acting is excluded from the definition of “U.S.
                                            person” pursuant to Rule 902(k)(2)(i) under the circumstances described in Rule
                                            902(h)(3)) and such offer and sale was not and will not be specifically targeted at an identifiable
                                            group of U.S. citizens abroad.

 

		2.	Unless the circumstances described in
                                            the parenthetical in paragraph 1 above are applicable, either (a) at the time the buy order
                                            was originated, the buyer was outside the United States or we and any person acting on our
                                            behalf reasonably believed that the buyer was outside the United States or (b) the transaction
                                            was executed in, on or through the facilities of a designated offshore securities market,
                                            and neither we nor any person acting on our behalf knows that the transaction was pre-arranged
                                            with a buyer in the United States.

 

		3.	Neither we, any of our affiliates, nor
                                            any person acting on our or their behalf has made any directed selling efforts in the United
                                            States with respect to the Notes.

 

    Ex-F-1

     

    

		4.	The proposed transfer of Notes is not
                                            part of a plan or scheme to evade the registration requirements of the Securities Act.

 

		5.	If we are a dealer or a person receiving
                                            a selling concession, fee or other remuneration in respect of the Notes, and the proposed
                                            transfer takes place during the Restricted Period (as defined in the Indenture), or we are
                                            an officer or director of the Company or an Initial Purchaser (as defined in the Indenture),
                                            we certify that the proposed transfer is being made in accordance with the provisions of
                                            Rule 904(b) of Regulation S.

 

☐B.This Certificate
relates to our proposed exchange of $____ principal amount of Notes issued under the Indenture for an equal principal amount of Notes
to be held by us. We hereby certify as follows:

 

		1.	At the time the offer and sale of the
                                            Notes was made to us, either (i) we were not in the United States or (ii) we were excluded
                                            from the definition of “U.S. person” pursuant to Rule 902(k)(2)(vi) or
                                            the account held by us for which we were acting was excluded from the definition of “U.S.
                                            person” pursuant to Rule 902(k)(2)(i) under the circumstances described in Rule
                                            902(h)(3); and we were not a member of an identifiable group of U.S. citizens abroad.

 

		2.	Unless the circumstances described in
                                            paragraph 1(ii) above are applicable, either (a) at the time our buy order was originated,
                                            we were outside the United States or (b) the transaction was executed in, on or through the
                                            facilities of a designated offshore securities market and we did not pre-arrange the transaction
                                            in the United States.

 

		3.	The proposed exchange of Notes is not
                                            part of a plan or scheme to evade the registration requirements of the Securities Act.

 

You and the Company
are entitled to rely upon this Certificate and are irrevocably authorized to produce this Certificate or a copy hereof to any interested
party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

 

	 	Very truly yours,
	 	 
	 	[NAME OF SELLER (FOR TRANSFERS) OR OWNER (FOR EXCHANGES)]
	 	 
	 	By:	      
	 	Name:	 
	 	Title:	 
	 	Address:	 

 

Date:________________

 

    Ex-F-2

     

    

Exhibit G

 

Rule 144A Certificate

 

		To:	U.S. Bank Trust Company, National Association,
                                            as Trustee (the “Trustee”)

                                            1 California Street, Suite 1000

San Francisco,
CA 94111

 Attention:
David Jason (Meta Platforms, Inc.)

 

Re:[3.500% Notes due 2027][3.850%
Notes due 2032][4.450% Notes due 2052][4.650% Notes due 2062] (the “Notes”) issued under the Indenture dated as
of August 9, 2022 between Meta Platforms, Inc. (the “Company”) and the Trustee, as supplemented by the First
Supplemental Indenture thereto dated as of August 9, 2022 (together, the “Indenture”)

 

Ladies and Gentlemen:

 

This Certificate
relates to:

 

[CHECK A OR B
AS APPLICABLE.]

 

		☐A.	Our proposed purchase of $____ principal
                                            amount of Notes issued under the Indenture.

 

		☐B.	Our proposed exchange of $____ principal
                                            amount of Notes issued under the Indenture for an equal principal amount of Notes to be held
                                            by us.

 

We and, if applicable,
each account for which we are acting in the aggregate owned and invested more than $100,000,000 in securities of issuers that are not
affiliated with us (or such accounts, if applicable), as of __________, 20__, which is a date on or since close of our most recent fiscal
year. We and, if applicable, each account for which we are acting, are a qualified institutional buyer within the meaning of Rule 144A
(“Rule 144A”) under the Securities Act of 1933, as amended (the “Securities Act”). If we are acting
on behalf of an account, we exercise sole investment discretion with respect to such account. We are aware that the transfer of Notes
to us, or such exchange, as applicable, is being made in reliance upon the exemption from the provisions of Section 5 of the Securities
Act provided by Rule 144A. Prior to the date of this Certificate we have received such information regarding the Company as we have requested
pursuant to Rule 144A(d)(4) or have determined not to request such information.

 

You and the Company
are entitled to rely upon this Certificate and are irrevocably authorized to produce this Certificate or a copy hereof to any interested
party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

 

	 	Very truly yours,
	 	 
	 	[NAME OF PURCHASER (FOR TRANSFERS) OR OWNER (FOR EXCHANGES)]
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	Address:	 

 

Date:________________

 

    Ex-G-1Exhibit 4.7

 

 

 

 

META PLATFORMS, INC.

 

$2,750,000,000 3.500% Senior Notes due 2027

$3,000,000,000 3.850% Senior Notes due 2032

$2,750,000,000 4.450% Senior Notes due 2052 

$1,500,000,000 4.650% Senior Notes due 2062

 

REGISTRATION RIGHTS AGREEMENT

 

Dated as of August 9, 2022

 

 

     

     

    

 

TABLE OF CONTENTS

 

	1.     DEFINITIONS	3
	2.     Exchange Offer	6
	3.     Shelf Registration	10
	4.     Additional Interest	11
	5.     Registration Procedures	12
	6.     Registration Expenses	20
	7.     Indemnification and Contribution	21
	8.     Rule 144A	25
	9.     NO Underwritten Registrations	25
	10.   Miscellaneous	25

 

    2 

     

    

THIS REGISTRATION RIGHTS AGREEMENT is dated as of
August 9, 2022 (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”),
and is entered into by and among Meta Platforms, Inc., a Delaware corporation (the “Company”),
and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, BofA Securities, Inc. and Barclays Capital Inc. as representatives (the
“Representatives”) of the several initial purchasers named on Schedule I to
the Purchase Agreement (as defined below) (collectively, the “Initial Purchasers”).

 

This Agreement is entered into in connection with
the Purchase Agreement, dated August 4, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase
Agreement”), by and among the Company and the Representatives on behalf of the Initial Purchasers, which provides for,
among other things, the sale by the Company to the Initial Purchasers of $10,000,000,000 in aggregate principal amount of the Company’s
3.500% senior notes due 2027 (the “2027 Notes”), 3.850% senior notes due 2032 (the “2032 Notes”),
4.450% senior notes due 2052 (the “2052 Notes”) and 4.650% senior notes due 2062 (the “2062 Notes”
and, together with the 2027 Notes, 2032 Notes and 2052 Notes, the “Securities”). The Securities are issued under a
base indenture, dated as of August 9, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “Base
Indenture”), by and between the Company and U.S. Bank Trust Company, National Association,
as trustee (the “Trustee”), as supplemented by the First Supplemental Indenture,
dated as of August 9, 2022 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”).
In order to induce the Initial Purchasers to enter into the Purchase Agreement, the Company has agreed to provide the registration rights
set forth in this Agreement for the benefit of the Initial Purchasers and, except as otherwise set forth herein, any subsequent holder
or holders of the Securities on the terms, and subject to the conditions, set forth herein.

 

The parties hereby agree as follows:

 

		1.	DEFINITIONS

 

As used in this Agreement, the following terms shall
have the following meanings:

 

Additional
Interest: See Section 4(a) hereof.

 

Additional
Interest Event: See Section 4(a) hereof.

 

Advice:
See the last paragraph of Section 5 hereof.

 

Agreement:
See the introductory paragraphs hereto.

 

Applicable
Period: See Section 2(b) hereof.

 

    3 

     

    

Business
Day: Shall have the meaning ascribed to such term in Rule 14d-1(g)(3) under the Exchange Act.

 

Company:
See the introductory paragraphs hereto.

 

Effectiveness
Period: See Section 3(a) hereof.

 

Exchange
Act: The Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder.

 

Exchange
Offer: See Section 2(a) hereof.

 

Exchange
Offer Registration Statement: See Section 2(a) hereof.

 

Exchange
Securities: See Section 2(a) hereof.

 

FINRA:
See Section 5(r) hereof.

 

Holder:
Any holder of a Transfer Restricted Security or Transfer Restricted Securities, including, where applicable, each Participating Broker-Dealer.

 

Indenture:
See the introductory paragraphs hereto.

 

Information:
See Section 5(n) hereof.

 

Initial
Purchasers: See the introductory paragraphs hereto.

 

Inspectors:
See Section 5(n) hereof.

 

Issue
Date: August 9, 2022, the date of original issuance of the Securities.

 

Participant:
See Section 7(a) hereof.

 

Participating
Broker-Dealer: See Section 2(b) hereof.

 

Person:
An individual, trustee, corporation, partnership, limited liability company, joint stock company, trust, unincorporated association, union,
business association, firm or other legal entity.

 

Private
Exchange: See Section 2(b) hereof.

 

Private
Exchange Notes: See Section 2(b) hereof.

 

    4 

     

    

Prospectus:
The prospectus included in any Registration Statement (including, without limitation, any prospectus subject to completion and a prospectus
that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon
Rule 430A or Rule 430B under the Securities Act and any term sheet filed pursuant to Rule 433 under the Securities Act), as amended or
supplemented by any prospectus supplement, and all other amendments and supplements to the Prospectus, including post-effective amendments,
and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

Purchase
Agreement: See the introductory paragraphs hereto.

 

Records:
See Section 5(n) hereof.

 

Registration
Statement: Any registration statement of the Company that covers any of the Securities, the Exchange Securities or the Private
Exchange Notes filed with the SEC under the Securities Act, including, in each case, the Prospectus, amendments and supplements to such
registration statement, including post-effective amendments, all exhibits, and all material incorporated by reference or deemed to be
incorporated by reference in such registration statement.

 

Representatives:
See the introductory paragraphs hereto.

 

Rule
144: Rule 144 under the Securities Act.

 

Rule
144A: Rule 144A under the Securities Act.

 

Rule
405: Rule 405 under the Securities Act.

 

Rule
415: Rule 415 under the Securities Act.

 

Rule
424: Rule 424 under the Securities Act.

 

SEC:
The U.S. Securities and Exchange Commission.

 

Securities:
See the introductory paragraphs hereto.

 

Securities
Act: The Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder.

 

Shelf
Notice: See Section 2(c) hereof.

 

Shelf
Registration: See Section 3(a) hereof.

 

Shelf
Registration Statement: Any Registration Statement relating to a Shelf Registration.

 

Shelf
Suspension Period: See Section 3(a) hereof.

 

    5 

     

    

TIA:
The Trust Indenture Act of 1939, as amended.

 

Transfer
Restricted Securities: Each Security upon its original issuance and at all times subsequent thereto, each Exchange Security
as to which Section 2(c)(iv) hereof is applicable upon original issuance and at all times subsequent thereto and each Private Exchange
Note upon original issuance thereof and at all times subsequent thereto, until, in each case, the earliest to occur of (i) a Registration
Statement (other than, with respect to any Exchange Securities as to which Section 2(c)(iv) hereof is applicable, the Exchange Offer Registration
Statement) covering such Security, Exchange Security or Private Exchange Note has been declared effective by the SEC and such Security,
Exchange Security or such Private Exchange Note, as the case may be, has been disposed of in accordance with such effective Registration
Statement, (ii) such Security has been exchanged pursuant to the Exchange Offer for an Exchange Security or Exchange Securities that may
be resold without restriction under state and federal securities laws, (iii) such Security, Exchange Security or Private Exchange Note,
as the case may be, ceases to be outstanding for purposes of the Indenture or (iv) the later of (x) the date which is two years after
the date the Securities were originally issued and (y) the date upon which such Security, Exchange Security or Private Exchange Note,
as the case may be, has been resold in compliance with Rule 144.

 

Trustee:
The trustee under the Indenture and the trustee under any indenture (if different) governing the Exchange Securities and Private Exchange
Notes.

 

Underwritten
registration or underwritten offering: A registration in which securities of the Company are sold to one or more underwriters
for reoffering to the public.

 

Except as otherwise specifically provided, all references
in this Agreement to acts, laws, statutes, rules, regulations, releases, forms, no-action letters and other regulatory requirements (collectively,
“Regulatory Requirements”) shall be deemed to refer also to any amendments
thereto and all subsequent Regulatory Requirements adopted as a replacement thereto having substantially the same effect therewith; provided
that Rule 144 shall not be deemed to amend or replace Rule 144A.

 

		2.	Exchange Offer

 

(a)              
Unless the Exchange Offer would violate applicable law or any applicable interpretation of the staff of the SEC, the Company shall,
at its expense, for the benefit of the Holders, use its commercially reasonable efforts to prepare and, no later than 270 days after the
Issue Date, file with the SEC a Registration Statement on an appropriate registration form (an “Exchange
Offer Registration Statement”) with respect to a registered offer (the “Exchange
Offer”) to exchange any and all of the Transfer Restricted Securities for a like aggregate principal amount of debt securities
of the same series of the Company (such debt securities, the “Exchange Securities”),
that are substantially identical in all material respects to the Securities, except that the Exchange Securities (i) shall contain no
restrictive legend thereon, (ii) shall accrue interest from (A) the later of (x) the last interest payment date on which interest was
paid on such Securities or (y) if such Securities are surrendered for exchange on a date in a

 

    6 

     

    

period that
includes the record date for an interest payment date to occur on or after the date of such exchange and as to which interest will be
paid, the date of such interest payment date or (B) if no interest has been paid on such Securities, from the Issue Date and (iii) shall
be entitled to the benefits of the Indenture or a trust indenture which is identical in all material respects to the Indenture (other
than such changes to the Indenture or any such identical trust indenture as are necessary to comply with the TIA) and which, in either
case, has been qualified under the TIA. The Company shall use its commercially reasonable efforts to cause the Exchange Offer Registration
Statement to be declared effective under the Securities Act within 365 days after the Issue Date. Promptly after an Exchange Offer Registration
Statement is declared effective, the Company shall commence the Exchange Offer. The Exchange Offer shall comply with all applicable tender
offer rules and regulations under the Exchange Act and other applicable federal and state securities laws. The Company shall use commercially
reasonable efforts to (x) keep the Exchange Offer open for at least 20 Business Days (or longer if required by applicable law) after
the date that notice of the Exchange Offer is transmitted to Holders and (y) consummate the Exchange Offer on or prior to the 395th day
following the Issue Date.

 

Each Holder (including, without limitation, each
Participating Broker-Dealer) that participates in the Exchange Offer, as a condition to participation in the Exchange Offer and consummation
by the Company of the Exchange Offer, will be required to represent to the Company in writing (which may be contained in the applicable
letter of transmittal) substantially to the effect that: (i) any Exchange Securities acquired in exchange for Transfer Restricted Securities
tendered are being acquired in the ordinary course of business of the Person receiving such Exchange Securities, whether or not such recipient
is such Holder itself; (ii) at the time of the commencement or consummation of the Exchange Offer, neither such Holder nor, to the knowledge
of such Holder, any other Person receiving Exchange Securities from such Holder has an arrangement or understanding with any Person to
participate in the distribution (within the meaning of the Securities Act) of the Exchange Securities in violation of the provisions of
the Securities Act; (iii) neither such Holder nor, to the knowledge of such Holder, any other Person receiving Exchange Securities from
such Holder is an “affiliate” (as defined in Rule 405) of the Company; (iv) if such Holder is not a broker-dealer, neither
such Holder nor, to the knowledge of such Holder, any other Person receiving Exchange Securities from such Holder is engaging, or intends
to engage, in a distribution of the Exchange Securities; and (v) if such Holder is a Participating Broker-Dealer, such Holder has acquired
the Transfer Restricted Securities for its own account in exchange for Securities that were acquired as a result of market-making activities
or other trading activities and will comply with the applicable provisions of the Securities Act (including, but not limited to, the prospectus
delivery requirements thereunder). In addition, all Holders of Transfer Restricted Securities shall otherwise cooperate in the Company’s
preparations for the Exchange Offer.

 

Upon consummation of the Exchange Offer in accordance
with this Section 2, the provisions of this Agreement shall continue to apply, mutatis mutandis, solely with respect to Transfer
Restricted Securities that are Private Exchange Notes, Exchange Securities as to which Section 2(c)(iv) hereof is applicable and Exchange
Securities held by Participating Broker-Dealers, and the Company shall have no further obligation to register Transfer Restricted Securities
(other than Private Exchange Notes and Exchange Securities as to which clause 2(c)(iv) hereof applies) pursuant to Section 3 hereof.

 

    7 

     

    

(b)              
The Company shall include within the Prospectus contained in the Exchange Offer Registration Statement a section entitled “Plan
of Distribution,” which shall contain a summary statement of the positions taken or policies made by the staff of the
SEC with respect to the potential “underwriter” status of any broker-dealer that is the “beneficial owner” (as
defined in Rule 13d-3 under the Exchange Act) of Exchange Securities received by such broker-dealer in the Exchange Offer (a “Participating
Broker-Dealer”), whether such positions or policies have been publicly disseminated by the staff of the SEC or such positions
or policies represent the prevailing views of the staff of the SEC. Such “Plan of Distribution” section shall also expressly
permit, to the extent permitted by applicable policies and regulations of the SEC, the use of the Prospectus by all Participating Broker-Dealers,
and include a statement describing the means by which Participating Broker-Dealers may resell the Exchange Securities in compliance with
the Securities Act.

 

The Company shall use its commercially reasonable
efforts to keep the Exchange Offer Registration Statement effective and to amend and supplement the Prospectus contained therein in order
to permit such Prospectus to be lawfully delivered by all Persons subject to the prospectus delivery requirements of the Securities Act
for such period of time as is necessary to comply with applicable law in connection with any resale of the Exchange Securities; provided,
however, that such period shall not be required to exceed 90 days after the date on which the Exchange Offer Registration Statement
is declared effective, as such period is extended, if at all, pursuant to the last paragraph of Section 5 hereof (the “Applicable
Period”).

 

If, immediately prior to the consummation of the
Exchange Offer, the Initial Purchasers hold any Securities acquired by them that have the status of an unsold allotment in the initial
distribution, the Company, upon the written request of the Initial Purchasers, shall simultaneously with the delivery of the Exchange
Securities issue and deliver to the Initial Purchasers, in exchange (the “Private
Exchange”) for such Securities held by any such Initial Purchaser, a like principal amount of notes of the Company (the
“Private Exchange Notes”), that are identical in all material
respects to the Exchange Securities except for the placement of a restrictive legend on such Private Exchange Notes. The Private Exchange
Notes shall be issued pursuant to the same indenture as the Exchange Securities and bear the same CUSIP number as the Exchange Securities
if permitted by the CUSIP Service Bureau.

 

In connection with the Exchange Offer, the Company
shall:

 

(1)              
make available to each Holder of record entitled to participate in the Exchange Offer a copy of the Prospectus forming part of
the Exchange Offer Registration Statement, together with an appropriate letter of transmittal and related documents;

 

(2)              
use its commercially reasonable efforts to keep the Exchange Offer open for not less than 20 Business Days (or longer if required
by applicable law) after the date that notice of the Exchange Offer is transmitted to Holders;

 

    8 

     

    

(3)              
utilize the services of a depositary for the Exchange Offer with an address in the United States;

 

(4)              
permit Holders to withdraw tendered Securities at any time prior to the close of business, New York time, on the last Business
Day on which the Exchange Offer remains open; and

 

(5)              
otherwise comply in all material respects with all laws, rules and regulations applicable to the Exchange Offer.

 

As soon as reasonably practicable after the close
of the Exchange Offer and any Private Exchange, the Company shall:

 

(1)              
accept for exchange all Transfer Restricted Securities validly tendered and not validly withdrawn pursuant to the Exchange Offer
and any Private Exchange;

 

(2)              
deliver to the Trustee for cancellation all Transfer Restricted Securities so accepted for exchange; and

 

(3)              
cause the Trustee to authenticate and deliver promptly to each Holder Exchange Securities or Private Exchange Notes, as the case
may be, equal in principal amount to the Securities of such Holder so accepted for exchange; provided that, in the case of any
Securities held in global form by a depositary, authentication and delivery to such depositary of one or more replacement Securities in
global form in an equivalent principal amount thereto for the account of such Holders in accordance with the Indenture shall satisfy such
authentication and delivery requirement.

 

The Exchange Offer and the Private Exchange shall
not be subject to any conditions, other than that (i) the Exchange Offer or Private Exchange, as the case may be, does not violate applicable
law or any applicable interpretation of the staff of the SEC; (ii) no action or proceeding shall have been instituted or threatened in
any court or by or before any governmental agency which, in the Company’s judgment, might materially impair the ability of the Company
to proceed with the Exchange Offer or the Private Exchange and, in the Company’s judgment, no material adverse development shall
have occurred in any existing action or proceeding with respect to the Company; (iii) all governmental approvals shall have been obtained,
which approvals the Company deems necessary for the consummation of the Exchange Offer or Private Exchange; and (iv) the accuracy of customary
representations of the Holders and other representations (including, but not limited to, those set forth in Section 2(a)) as may reasonably
be necessary under applicable SEC rules, regulations or interpretations, the satisfaction by the Holders of customary conditions relating
to the delivery of Securities and the execution and delivery of customary documentation relating to the Exchange Offer or Private Exchanges,
as applicable.

 

The Exchange Securities and the Private Exchange
Notes shall be issued under (i) the Indenture or (ii) an indenture substantially identical in all material respects to the Indenture and
which, in either case, has been qualified under the TIA or is exempt from such qualification and shall provide that the Exchange Securities
shall not be subject to the transfer restrictions set forth in the Indenture. The Indenture or such other indenture shall provide that
the Exchange

 

    9 

     

    

Securities, the Private Exchange Notes and the Securities
shall vote and consent together on all matters as one class and that none of the Exchange Securities, the Private Exchange Notes or the
Securities will have the right to vote or consent as a separate class on any matter.

 

(c)              
If (i) because of any change in law or in currently prevailing interpretations of the staff of the SEC, the Company is not permitted
to effect the Exchange Offer, (ii) the Exchange Offer is not consummated by the 395th day following the Issue Date, (iii) any holder of
Private Exchange Notes so requests in writing to the Company at any time within 20 days after the consummation of the Exchange Offer,
or (iv) in the case of any Holder that participates in the Exchange Offer, such Holder does not receive Exchange Securities on the date
of the exchange that may be sold without restriction under state and federal securities laws (other than due solely to the status of such
Holder as an affiliate of the Company within the meaning of the Securities Act) and so notifies the Company within 10 days after such
Holder first becomes aware of such restrictions (but in any event no later than 20 days after the consummation of the Exchange Offer),
in the case of each of clauses (i) through (iv) of this sentence, then the Company shall promptly deliver to the Trustee (to deliver to
the Holders) written notice thereof (the “Shelf Notice”)
and shall use commercially reasonable efforts to file a Shelf Registration pursuant to Section 3 hereof.

 

3.                 
Shelf Registration

 

If at any time a Shelf Notice is delivered as contemplated
by Section 2(c) hereof, then:

 

(a)              
Shelf Registration. The Company shall, at its expense, use its commercially reasonable efforts to file with the SEC a Registration
Statement for an offering to be made on a continuous basis pursuant to Rule 415 covering all of the Transfer Restricted Securities (the
“Shelf Registration”) as soon as practicable after the
filing obligation arises; provided, however, that (i) nothing in this Section 3(a) shall require the Company to file the Shelf
Registration Statement prior to the deadline for filing the Exchange Offer Registration Statement set forth in Section 2(a) and (ii) in
the event the Exchange Offer is consummated within 395 days after the Issue Date, the Company shall not have any obligation to file the
Shelf Registration Statement pursuant to this Section 3. The Shelf Registration shall be on Form S-3 or another appropriate form permitting
registration of such Transfer Restricted Securities for resale by Holders in the manner or manners designated by them (including, without
limitation, one or more underwritten offerings). Notwithstanding anything to the contrary herein, no Holder shall be entitled to be named
as a selling security holder in the Shelf Registration Statement or to use the Prospectus forming a part thereof for resales of Transfer
Restricted Securities unless such Holder has signed and returned to the Company a notice and questionnaire as distributed by the Company
consenting to such Holder’s inclusion in the Prospectus as a selling security holder, evidencing such Holder’s agreement to
be bound by the applicable provisions of this Agreement and providing such further information to the Company as the Company may reasonably
request.

 

The Company shall use commercially reasonable efforts
to cause the Shelf Registration to be declared effective under the Securities Act within 270 days after the date, if any, on which the
Company became obligated to file the Shelf Registration Statement and to

 

    10 

     

    

keep the Shelf Registration continuously effective
under the Securities Act until the date upon which all Transfer Restricted Securities eligible to be sold thereunder have been sold pursuant
to the Shelf Registration Statement or are freely tradeable pursuant to Rule 144 under the Securities Act and the applicable interpretations
of the SEC or cease to be outstanding or otherwise to be Transfer Restricted Securities (the “Effectiveness
Period”). Notwithstanding anything to the contrary in this Agreement, at any time, the Company may delay the filing of
any Shelf Registration or delay or suspend the effectiveness thereof, for a reasonable period of time, but not in excess of 60 consecutive
days or more than three (3) times during any calendar year (each, a “Shelf
Suspension Period”), if the Board of Directors of the Company determines reasonably and in good faith that the filing
of the Shelf Registration or the continuing effectiveness thereof would require the disclosure of non-public material information that,
in the reasonable judgment of the Board of Directors of the Company, would be detrimental to the Company if so disclosed or would otherwise
materially adversely affect a financing, acquisition, disposition, merger or other material transaction or such action is required by
applicable law; provided, however, that in no event shall the Company be required to disclose the business purpose for such delay
or suspension. Any Shelf Suspension Period pursuant to this Section 3(a) shall begin on the date specified in a written notice given by
the Company to the Holders and shall end on the date specified in a subsequent written notice given by the Company to the Holders.

 

(b)              
Withdrawal of Stop Orders. If the Shelf Registration ceases to be effective for any reason at any time during the Effectiveness
Period (other than in the case of Shelf Suspension Period(s) permitted by this Agreement or because of the sale of all of the Securities
registered thereunder), the Company shall use commercially reasonable efforts to obtain the prompt withdrawal of any order suspending
the effectiveness thereof.

 

(c)              
Supplements and Amendments. The Company shall promptly supplement and/or amend the Shelf Registration if (i) required by
the rules, regulations or instructions applicable to the registration form used for such Shelf Registration, (ii) required by the Securities
Act (iii) reasonably requested by the Holders of a majority in aggregate principal amount of the Transfer Restricted Securities covered
by such Registration Statement with respect to the information included therein with respect to one or more of such Holders or (iv) reasonably
requested by any underwriter of such Transfer Restricted Securities with respect to the information included therein with respect to such
underwriter.

 

		4.	Additional Interest

 

(a)              
The Company and the Initial Purchasers agree that the Holders will suffer damages if the Company fails to fulfill its obligations
under Section 2 or Section 3 hereof, as further specified in this Section 4, and that it would not be feasible to ascertain the extent
of such damages with precision. Accordingly, the Company agrees to pay, as liquidated damages, additional interest on the Securities (“Additional
Interest”) if (A) the Company has neither (i) exchanged Exchange Securities for all Transfer Restricted Securities validly
tendered in accordance with the terms of the Exchange Offer on or prior to the 395th day following the Issue Date nor (ii) if applicable,
had a Shelf Registration Statement declared effective under the Securities Act on or prior to the 270th day after the date that such Shelf
Registration is required to be declared effective determined in accordance with Section 2(c) and

 

    11 

     

    

3(a) hereof,
or (B) if applicable, a Shelf Registration has been declared effective and such Shelf Registration ceases to be effective at any time
during the Effectiveness Period (other than in the case of Shelf Suspension Period(s) permitted by this Agreement or because of the sale
of all of the Securities registered thereunder) (each such event referred to in clauses (A) and (B), an “Additional
Interest Event”), then Additional Interest shall accrue on the principal amount of the Securities then outstanding (but,
following the consummation of the Exchange Offer, only on the principal amount of such Securities that could not be exchanged or were
not exchanged as specified in Section 2(c) hereof) at a rate of 0.25% per annum during the 90-day period immediately following the occurrence
of any Additional Interest Event, which rate will, after such 90-day period, increase to a maximum of 0.50% per annum thereafter (such
Additional Interest to be calculated by the Company) commencing on the (x) 396th day after the Issue Date, in the case of clause (A)(i)
above, (y) such later date that a Shelf Registration is required to be declared effective determined in accordance with Section 2(c)
and 3(a) hereof, in the case of clause (A)(ii) above, or (z) the day such Shelf Registration ceases to be effective in the case of clause
(B) above; provided, however, that upon the exchange of the Exchange Securities for all Transfer Restricted Securities validly
tendered (in the case of clause (A) of this Section 4(a)) or upon the effectiveness of the applicable Shelf Registration Statement which
had ceased to remain effective (in the case of clause (B) of this Section 4(a)) or if the Securities otherwise no longer constitute
Transfer Restricted Securities, Additional Interest on the Securities in respect of which such events relate as a result of such clause
(or the relevant subclause thereof), as the case may be, shall cease to accrue. The obligation of the Company to pay Additional Interest
as set forth in this Section 4 shall be the sole and exclusive remedy, monetary or otherwise, of the Holders and Participating Broker-Dealers
for any Additional Interest Event. Notwithstanding anything to the contrary herein, (i) the amount of Additional Interest payable shall
not increase because more than one Additional Interest Event has occurred and is continuing, (ii) a Holder or Participating Broker-Dealer
that is not entitled to the benefits of the Shelf Registration shall not be entitled to Additional Interest with respect to any Additional
Interest Event that pertains to the Shelf Registration and (iii) the Company shall not be obligated to pay Additional Interest provided
in this Section 4 during a Shelf Suspension Period permitted by Section 3(a) hereof. For the avoidance of doubt, following the cure of
all Additional Interest Events, the accrual of Additional Interest on the affected Securities will cease, the interest rate will revert
to the original rate on such Securities and, upon any subsequent Additional Interest Event following any such cure of all Additional
Interest Events, Additional Interest will begin accruing again at 0.25% per annum and will increase to a maximum of 0.50% per annum as
provided above until all Additional Interest Events have been cured.

 

(b)              
The Company shall notify the Trustee within five Business Days after the occurrence of an Additional Interest Event in respect
of which Additional Interest is required to be paid. Any amounts of Additional Interest due pursuant to clause (a) of this Section 4 shall
be paid by depositing with the Trustee, in trust, for the benefit of the Holders of the Transfer Restricted Securities entitled to such
Additional Interest, on or before the applicable semi-annual interest payment date set forth in the Indenture, immediately available funds
in sums sufficient to pay the Additional Interest then due. The Additional Interest due shall be payable on each interest payment date
to the record Holder of the Transfer Restricted Securities affected thereby entitled to receive the interest payment to be paid on such
date as set forth in the Indenture. The amount of Additional Interest will be determined by the Company by multiplying the applicable
Additional Interest rate by the applicable principal amount of the Transfer Restricted Securities

 

    12 

     

    

entitled
to such Additional Interest (as determined pursuant to Section 4(a) hereof), multiplied by a fraction, the numerator of which is the
number of days such Additional Interest rate was applicable during such period (determined on the basis of a 360-day year consisting
of twelve 30-day months and, in the case of a partial month, the actual number of days elapsed), and the denominator of which is 360.
Each obligation to pay Additional Interest shall be deemed to accrue from and including the day following the applicable Additional Interest
Event.

 

		5.	Registration Procedures

 

In connection with the filing of any Registration
Statement pursuant to Section 2 or 3 hereof, the Company shall use its commercially reasonable efforts to effect such registrations to
permit the sale of the securities covered thereby in accordance with the intended method or methods of disposition thereof, and pursuant
thereto and in connection with any Registration Statement filed by the Company hereunder, the Company shall:

 

(a)              
Use its commercially reasonable efforts to prepare and file with the SEC, a Registration Statement as prescribed by Section 2 or
3 hereof, and use its commercially reasonable efforts to cause each such Registration Statement to become effective and remain effective
as provided herein; provided, however, that if (1) such filing is pursuant to Section 3 hereof or (2) a Prospectus contained in
the Exchange Offer Registration Statement filed pursuant to Section 2 hereof is required to be delivered under the Securities Act by any
Participating Broker-Dealer who seeks to sell Exchange Securities during the Applicable Period relating thereto from whom the Company
has received prior written notice that it will be a Participating Broker-Dealer in the Exchange Offer, before filing any Registration
Statement or Prospectus or any amendments or supplements thereto, the Company shall furnish to and afford counsel for the Holders of the
Transfer Restricted Securities covered by such Registration Statement (with respect to a Registration Statement filed pursuant to Section
3 hereof), which shall be a single firm and which shall be Skadden, Arps, Slate, Meagher & Flom LLP or such other firm selected by
the Holders holding a majority in principal amount of the Transfer Restricted Securities covered by such Registration Statement or counsel
for such Participating Broker-Dealer (with respect to any such Registration Statement), as the case may be, and counsel to the managing
underwriters, if any, a reasonable opportunity to review copies of all such documents (including copies of any documents to be incorporated
by reference therein and all exhibits thereto) proposed to be filed (in each case at least three Business Days prior to such filing).
The Company shall not file any Registration Statement or Prospectus or any amendments or supplements thereto (other than Exchange Act
filings incorporated by reference in any Registration Statement or Prospectus or any amendments or supplements thereto) if the Holders
of a majority in aggregate principal amount of the Transfer Restricted Securities covered by such Registration Statement, their counsel,
or the managing underwriters, if any, shall reasonably object.

 

(b)              
Subject to Section 3(a), prepare and file with the SEC such amendments and post-effective amendments to each Shelf Registration
Statement or Exchange Offer Registration Statement, as the case may be, as may be necessary to keep such Registration Statement continuously
effective for the Effectiveness Period, the Applicable Period or until consummation of the Exchange Offer, as the case may be; cause the
related Prospectus to be supplemented by any Prospectus supplement required by applicable law, and as so supplemented

 

    13 

     

    

to be filed
pursuant to Rule 424 (or any similar provision then in force); and comply with the provisions of the Securities Act and the Exchange
Act applicable to it with respect to the disposition of all securities covered by such Registration Statement as so amended or in such
Prospectus as so supplemented and with respect to the subsequent resale of any securities being sold by a Participating Broker-Dealer
covered by any such Prospectus in all material respects; provided, however, that nothing contained herein shall imply that the Company
is liable for any action or inaction of any Holder, including any Participating Broker-Dealer.

 

(c)              
If (1) a Shelf Registration is filed pursuant to Section 3 hereof or (2) a Prospectus contained in the Exchange Offer Registration
Statement filed pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Securities during the Applicable Period relating thereto from whom the Company has received prior written notice
that it will be a Participating Broker-Dealer in the Exchange Offer, notify the selling Holders of Transfer Restricted Securities (with
respect to a Registration Statement filed pursuant to Section 3 hereof) or each such Participating Broker-Dealer (with respect to any
such Registration Statement), as the case may be, their counsel and the managing underwriters, if any, promptly (but in any event within
three Business Days) (i) when a Prospectus or any Prospectus supplement or post-effective amendment has been filed, and, with respect
to a Registration Statement or any post-effective amendment, when the same has become effective under the Securities Act (including in
such notice a written statement that any Holder may, upon request, obtain, at the sole expense of the Company, one conformed copy of such
Registration Statement or post-effective amendment including financial statements and schedules, documents incorporated or deemed to be
incorporated by reference and exhibits), (ii) of the issuance by the SEC of any stop order suspending the effectiveness of a Registration
Statement or of any order preventing or suspending the use of any preliminary prospectus or the initiation of any proceedings for that
purpose, (iii) if at any time when a prospectus is required by the Securities Act to be delivered in connection with sales of the Transfer
Restricted Securities or resales of Exchange Securities by Participating Broker-Dealers the representations and warranties of the Company
contained in any agreement (including any underwriting agreement) contemplated by Section 5(m) hereof cease to be true and correct in
all material respects, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of a Registration Statement or any of the Transfer Restricted Securities or the Exchange Securities to be sold by any
Participating Broker-Dealer for offer or sale in any jurisdiction, or the initiation or threatening in writing of any proceeding for such
purpose, (v) of the happening of any event, the existence of any condition or any information becoming known that makes any statement
made in such Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein by reference
untrue in any material respect or that requires the making of any changes in or amendments or supplements to such Registration Statement,
Prospectus or documents so that, in the case of the Registration Statement, it will not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and that
in the case of the Prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading,
and (vi) of the Company’s determination that a post-effective amendment to a Registration Statement would be appropriate.

 

    14 

     

    

(d)              
Use its commercially reasonable efforts to prevent the issuance of any order suspending the effectiveness of a Registration Statement
or of any order preventing or suspending the use of a Prospectus or suspending the qualification (or exemption from qualification) of
any of the Transfer Restricted Securities or the Exchange Securities to be sold by any Participating Broker-Dealer, for sale in any jurisdiction.

 

(e)              
If a Shelf Registration is filed pursuant to Section 3 hereof and if requested during the Effectiveness Period by the managing
underwriter or underwriters (if any) or the Holders of a majority in aggregate principal amount of the Transfer Restricted Securities
being sold in connection with an underwritten offering, (i) as promptly as practicable incorporate in a prospectus supplement or post-effective
amendment such information as the managing underwriter or underwriters (if any), such Holders or counsel for either of them reasonably
request to be included therein and (ii) make all required filings of such prospectus supplement or such post-effective amendment as soon
as practicable after the Company has received notification of the matters to be incorporated in such prospectus supplement or post-effective
amendment.

 

(f)               
If (1) a Shelf Registration is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration
Statement filed pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Securities during the Applicable Period, furnish to each selling Holder of Transfer Restricted Securities (with
respect to a Registration Statement filed pursuant to Section 3 hereof) and to each such Participating Broker-Dealer who so requests (with
respect to any such Registration Statement) and to their respective counsel and each managing underwriter, if any, upon request and at
the sole expense of the Company, one conformed copy of the Registration Statement or Registration Statements and each post-effective amendment
thereto, including financial statements and schedules, and, if requested, all documents incorporated or deemed to be incorporated therein
by reference and all exhibits.

 

(g)              
If (1) a Shelf Registration is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration
Statement filed pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Securities during the Applicable Period, deliver to each selling Holder of Transfer Restricted Securities (with
respect to a Registration Statement filed pursuant to Section 3 hereof), or each such Participating Broker-Dealer (with respect to any
such Registration Statement), as the case may be, their respective counsel, and the underwriters, if any, at the sole expense of the Company,
as many copies of the Prospectus or Prospectuses (including each form of preliminary prospectus) and each amendment or supplement thereto
and any documents incorporated by reference therein as such Persons may reasonably request; and, subject to the last paragraph of this
Section 5, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders
of Transfer Restricted Securities or each such Participating Broker-Dealer, as the case may be, and the underwriters or agents, if any,
and dealers, if any, in connection with the offering and sale of the Transfer Restricted Securities covered by, or the sale by Participating
Broker-Dealers of the Exchange Securities pursuant to, such Prospectus and any amendment or supplement thereto.

 

    15 

     

    

(h)              
Prior to any public offering of Transfer Restricted Securities or any delivery of a Prospectus contained in the Exchange Offer
Registration Statement by any Participating Broker-Dealer who seeks to sell Exchange Securities during the Applicable Period, use its
commercially reasonable efforts to register or qualify, and to cooperate with the selling Holders of Transfer Restricted Securities or
each such Participating Broker-Dealer, as the case may be, the managing underwriter or underwriters, if any, and their respective counsel
in connection with the registration or qualification (or exemption from such registration or qualification) of such Transfer Restricted
Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions within the United States as any selling Holder,
Participating Broker-Dealer, or the managing underwriter or underwriters reasonably request in writing; provided, however, that
where Exchange Securities held by Participating Broker-Dealers or Transfer Restricted Securities are offered other than through an underwritten
offering, the Company agrees to use its commercially reasonable efforts to cause its counsel to perform Blue Sky investigations and file
registrations and qualifications required to be filed pursuant to this Section 5(h), keep each such registration or qualification (or
exemption therefrom) effective during the period such Registration Statement is required to be kept effective and do any and all other
acts or things necessary or advisable to enable the disposition in such jurisdictions of the Exchange Securities held by Participating
Broker-Dealers or the Transfer Restricted Securities covered by the applicable Registration Statement; provided, however, that
the Company shall not be required to (A) qualify generally to do business in any jurisdiction where they are not then so qualified, (B)
take any action that would subject them to general service of process or taxation in any such jurisdiction where they are not then so
subject or (C) make any changes to its certificate of incorporation or by-laws (or other organizational documents) or any agreement between
it and holders of its ownership interests.

 

(i)                
If a Shelf Registration is filed pursuant to Section 3 hereof, cooperate with the selling Holders of Transfer Restricted Securities
and the managing underwriter or underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Transfer
Restricted Securities to be sold, which certificates shall not bear any restrictive legends and shall be in a form eligible for deposit
with The Depository Trust Company; and enable such Transfer Restricted Securities to be in such denominations (subject to applicable requirements
contained in the Indenture) and registered in such names as the managing underwriter or underwriters, if any, or Holders may reasonably
request.

 

(j)                
[Reserved].

 

(k)              
If (1) a Shelf Registration is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration
Statement filed pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Securities during the Applicable Period, upon the occurrence of any event contemplated by Section 5(c)(v) or 5(c)(vi)
hereof, as promptly as practicable, use its commercially reasonable efforts to prepare and (subject to Section 5(a) hereof) file with
the SEC, at the sole expense of the Company, a supplement or post-effective amendment to the Registration Statement or a supplement to
the related Prospectus or any document incorporated therein by reference so that (but only to such an extent that), as thereafter delivered
to the purchasers of the Transfer Restricted Securities being sold thereunder (with respect to a Registration Statement filed pursuant
to Section 3 hereof) or to the purchasers of the Exchange

 

    16 

     

    

Securities
to whom such Prospectus will be delivered by a Participating Broker-Dealer (with respect to any such Registration Statement), any such
Prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

(l)                
Prior to the effective date of the Registration Statement relating to the Transfer Restricted Securities, (i) if then in certificated
form, provide the Trustee with certificates for the Transfer Restricted Securities in a form eligible for deposit with The Depository
Trust Company and (ii) provide a CUSIP number for the Transfer Restricted Securities.

 

(m)            
In connection with any underwritten offering of Transfer Restricted Securities pursuant to a Shelf Registration, enter into an
underwriting agreement as is customary in underwritten offerings of debt securities similar to the Securities (including, without limitation,
a customary condition to the obligations of the underwriters that the underwriters shall have received “cold comfort” letters
and updates thereof in form, scope and substance reasonably satisfactory to the managing underwriter or underwriters from the independent
certified public accountants of the Company (and, if necessary, any other independent certified public accountants of the Company, or
of any business acquired by the Company, for which financial statements and financial data are, or are required to be, included or incorporated
by reference in the Registration Statement), addressed to each of the underwriters, such letters to be in customary form and covering
matters of the type customarily covered in “cold comfort” letters in connection with underwritten offerings of debt securities
similar to the Securities), and take all such other actions as are reasonably requested by the managing underwriter or underwriters in
order to expedite or facilitate the registration or the disposition of such Transfer Restricted Securities and, in such connection, (i)
make such representations and warranties to, and covenants with, the underwriters with respect to the business of the Company (including
any acquired business, properties or entity, if applicable), and the Registration Statement, Prospectus and documents, if any, incorporated
or deemed to be incorporated by reference therein, in each case, as are customarily made by companies to underwriters in underwritten
offerings of debt securities similar to the Securities; and (ii) use its commercially reasonable efforts to obtain the written opinions
of counsel to the Company in form, scope and substance reasonably satisfactory to the managing underwriter or underwriters, addressed
to the underwriters covering the matters customarily covered in opinions reasonably requested in underwritten offerings (it being agreed
that Davis Polk & Wardwell LLP is deemed to be counsel that is reasonably acceptable). The above shall be done at each closing under
such underwriting agreement, or as and to the extent required thereunder.

 

(n)              
If (1) a Shelf Registration is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration
Statement filed pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Securities during the Applicable Period, make available for inspection by any Initial Purchaser, by one representative
selected by the Holders holding a majority in principal amount of such Transfer Restricted Securities being sold (with respect to a Registration
Statement filed pursuant to Section 3 hereof), or each such Participating Broker-Dealer, as the case may be, any underwriter participating
in any such disposition of Transfer

 

    17 

     

    

Restricted
Securities, if any, and any attorney (which shall be a single firm and which shall be Skadden, Arps, Slate, Meagher & Flom LLP or
such other firm selected by the Holders holding a majority in principal amount of the Transfer Restricted Securities covered by such
Registration Statement), accountant or other agent retained by any such selling Holder or each such Participating Broker-Dealer (with
respect to any such Registration Statement), as the case may be, or underwriter (any such Initial Purchasers, Holders, Participating
Broker-Dealers, underwriters, attorneys, accountants or agents, collectively, the “Inspectors”),
upon written request, at reasonable times and in a reasonable manner, all pertinent financial and other records, pertinent corporate
documents and instruments of the Company and subsidiaries of the Company (collectively, the “Records”),
as shall be reasonably necessary to enable them to exercise any applicable reasonable due diligence responsibilities, and cause the officers,
directors and employees of the Company and any of its subsidiaries to supply, during reasonable business hours, all information (“Information”)
reasonably requested by any such Inspector in connection with such due diligence responsibilities. Each Inspector shall agree in writing
that it will keep the Records and Information confidential, to use the Records and Information only to the extent necessary for due diligence
purposes under applicable securities laws, to abstain from using the Records or the Information as the basis for any market transactions
in Securities of the Company (or for any purpose other than the satisfaction of its due diligence responsibilities in connection with
such Shelf Registration or Exchange Offer Registration Statement, as applicable) and that it will not disclose any of the Records or
Information that the Company determines, in good faith, to be confidential and notifies the Inspectors in writing are confidential unless
(i) the disclosure of such Records or Information is necessary to avoid or correct a material misstatement or omission in such Registration
Statement or Prospectus (in the case of any Prospectus, considered in the light of the circumstances under which it was made), (ii) the
release of such Records or Information is ordered pursuant to a subpoena or other order from a court of competent jurisdiction, (iii)
disclosure of such Records or Information is necessary or advisable, in the reasonable opinion of counsel for any Inspector, in connection
with any action, claim, suit or proceeding, directly or indirectly, involving or potentially involving such Inspector and arising out
of, based upon, relating to, or involving this Agreement or the Purchase Agreement, or any transactions contemplated hereby or thereby
or arising hereunder or thereunder, or (iv) the information in such Records or Information has been made generally available to the public
other than as a result of a disclosure or failure to safeguard such Records and Information by an Inspector or an “affiliate”
(as defined in Rule 405) thereof; provided, that the foregoing gathering of Records and Information by the Inspectors shall, to
the greatest extent possible, be coordinated on behalf of Holders and any other parties entitled thereto (including any Participating
Broker-Dealers) by one counsel designated by them; and provided, further, that prior written notice shall be provided as soon
as practicable to the Company of the potential disclosure of any information by such Inspector pursuant to clauses (i) or (ii) of this
sentence to permit the Company to obtain a protective order (or waive the provisions of this paragraph (n)) and that such Inspector shall
take such actions as are reasonably necessary to protect the confidentiality of such information.

 

(o)              
Provide an indenture trustee for the Transfer Restricted Securities or the Exchange Securities, as the case may be, and cause the
Indenture or the trust indenture provided for in Section 2(a) hereof, as the case may be, to be qualified under the TIA not later than
the effective date of the Registration Statement relating to the Transfer Restricted Securities; and in connection therewith, cooperate
with the trustee under any such indenture and the Holders of the

 

    18 

     

    

Transfer
Restricted Securities, to effect such changes (if any) to such indenture as may be required for such indenture to be so qualified in
accordance with the terms of the TIA; and execute, and use its commercially reasonable efforts to cause such trustee to execute, all
documents as may be required to effect such changes, and all other forms and documents required to be filed with the SEC to enable such
indenture to be so qualified in a timely manner.

 

(p)              
Comply in all material respects with all applicable rules and regulations of the SEC, and make generally available to their securityholders
with regard to any applicable Registration Statement a consolidated earnings statement (which need not be audited) satisfying the provisions
of Section 11(a) of the Securities Act and Rule 158 thereunder (or any similar rule promulgated under the Securities Act) for the 12-month
period beginning with the first month of the Company’s first fiscal quarter commencing after the effective date of the first Registration
Statement required by this Agreement; provided that this requirement shall be deemed satisfied by the Company by complying with
the applicable reporting covenant of the Indenture.

 

(q)              
If the Exchange Offer or a Private Exchange is to be consummated, upon delivery of the Transfer Restricted Securities by Holders
to the Company (or to such other Person as directed by the Company), in exchange for the Exchange Securities or the Private Exchange Notes,
as the case may be, if then in certificated form, the Company shall mark, or cause to be marked, on such Transfer Restricted Securities
that such Transfer Restricted Securities are being cancelled in exchange for the Exchange Securities or the Private Exchange Notes, as
the case may be; in no event shall such Transfer Restricted Securities be marked as paid or otherwise satisfied.

 

(r)               
Cooperate with each seller of Transfer Restricted Securities covered by any Registration Statement and each underwriter, if any
(including any “qualified independent underwriter” that is required to be retained in accordance with the rules and regulations
of the Financial Industry Regulatory Authority, Inc. (“FINRA”)),
participating in the disposition of such Transfer Restricted Securities and their respective counsel in connection with any filings required
to be made with FINRA.

 

(s)               
Use its commercially reasonable efforts to take all other steps reasonably necessary to effect the registration of the Exchange
Securities and/or Transfer Restricted Securities covered by a Registration Statement contemplated hereby.

 

The Company may require each seller of Transfer Restricted
Securities as to which any registration is being effected to furnish to the Company in writing such information regarding such seller
and the distribution of such Transfer Restricted Securities as the Company may, from time to time, reasonably request. The Company may
exclude from such registration the Transfer Restricted Securities of any seller so long as such seller fails to furnish such information
in writing within a reasonable time after receiving such request. Each seller as to which any Shelf Registration is being effected agrees
to furnish promptly in writing to the Company all information required to be disclosed in order to make the information previously furnished
to the Company by such seller not materially misleading.

 

    19 

     

    

If any such Registration Statement refers to any
Holder by name or otherwise as the holder of any securities of the Company, then such Holder shall have the right to require (to the extent
not objected to by the SEC) (i) the insertion therein of language, in form and substance reasonably satisfactory to such Holder, to the
effect that the holding by such Holder of such securities is not to be construed as a recommendation by such Holder of the investment
quality of the securities covered thereby and that such holding does not imply that such Holder will assist in meeting any future financial
requirements of the Company or (ii) in the event that such reference to such Holder by name or otherwise is not required by the Securities
Act or any similar federal statute then in force, the deletion of the reference to such Holder in any amendment or supplement to the Registration
Statement filed or prepared subsequent to the time that such reference ceases to be required.

 

Each Holder of Transfer Restricted Securities and
each Participating Broker-Dealer agrees by its acquisition of such Transfer Restricted Securities or Exchange Securities to be sold by
such Participating Broker-Dealer, as the case may be, that, upon receipt of any notice from the Company of the happening of any event
of the kind described in Section 5(c)(ii), 5(c)(iv), 5(c)(v), or 5(c)(vi) hereof, such Holder shall forthwith discontinue disposition
of such Transfer Restricted Securities covered by such Registration Statement or Prospectus or Exchange Securities to be sold by such
Holder or Participating Broker-Dealer, as the case may be, until such Holder’s or Participating Broker-Dealer’s receipt of
the copies of the supplemented or amended Prospectus contemplated by Section 5(k) hereof, or until it is advised in writing (the “Advice”)
by the Company that the use of the applicable Prospectus may be resumed, and has received copies of any amendments or supplements thereto.
In the event that the Company shall give any such notice, each of the Applicable Period and the Effectiveness Period shall be extended
by the number of days during such periods from and including the date of the giving of such notice to and including the date when each
seller of Transfer Restricted Securities covered by such Registration Statement or Exchange Securities to be sold by such Participating
Broker-Dealer, as the case may be, shall have received (x) the copies of the supplemented or amended Prospectus contemplated by Section
5(k) hereof or (y) the Advice.

 

6.                 
Registration Expenses

 

(a)              
All fees and expenses incident to the performance of or compliance with this Agreement by the Company of its obligations under
Sections 2, 3, 5 and 8 hereof shall be borne by the Company whether or not the Exchange Offer Registration Statement or any Shelf Registration
Statement is filed or becomes effective or the Exchange Offer is consummated, including, without limitation, (i) all registration and
filing fees (including, without limitation, (A) fees with respect to filings required to be made with FINRA in connection with an underwritten
offering and (B) fees and expenses of compliance with state securities or Blue Sky laws (including, without limitation, reasonable fees
and disbursements of counsel in connection with Blue Sky qualifications of the Transfer Restricted Securities or Exchange Securities as
provided in Section 5(h) hereof)), (ii) printing expenses, including, without limitation, printing Prospectuses if the printing of Prospectuses
is requested by the managing underwriter or underwriters, if any, by the Holders of a majority in aggregate principal amount of the Transfer
Restricted Securities included in any Registration Statement, or in respect of Transfer Restricted Securities or Exchange Securities to
be sold by any Participating Broker-Dealer during the Applicable Period, as the case may be, (iii) fees and expenses of the Trustee and
any exchange agent retained by the Company and their counsel, (iv) fees and disbursements of counsel for the Company and, in the case
of a Shelf Registration, subject to Section 6(b), reasonable and

 

    20 

     

    

documented
fees and disbursements of one firm of counsel for all of the sellers of Transfer Restricted Securities selected by the Holders of a majority
in aggregate principal amount of Transfer Restricted Securities covered by such Shelf Registration (which counsel shall be reasonably
satisfactory to the Company) exclusive of any counsel retained pursuant to Section 7 hereof and (v) fees and disbursements of all independent
certified public accountants referred to in Section 5(m) hereof (including, without limitation, the expenses of any “cold comfort”
letters required by or incident to such performance); provided, however, that each Holder shall pay all underwriting discounts
and commissions and transfer taxes, of any, relating to the sale and disposition of such Holder’s Transfer Restricted Securities
pursuant to the Shelf Registration Statement.

 

(b)              
In connection with any Registration Statement required by this Agreement (other than the Exchange Offer Registration Statement),
the Company will reimburse the Initial Purchasers and the Holders of Transfer Restricted Securities being resold pursuant to the “Plan
of Distribution” contained in the Shelf Registration Statement for the reasonable fees and disbursements of not more
than one counsel, who shall be Skadden, Arps, Slate, Meagher & Flom LLP or such other counsel as may be chosen by the Holders of a
majority in principal amount of the Transfer Restricted Securities for whose benefit such Shelf Registration Statement is being prepared.

 

7.                 
Indemnification and Contribution

 

(a)              
The Company agrees to indemnify and hold harmless each Initial Purchaser, each Holder of Transfer Restricted Securities and each
Participating Broker-Dealer selling Exchange Securities during the Applicable Period, and each Person, if any, who controls such Person
or its affiliates within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each, a “Participant”)
against any losses, claims, damages or liabilities, joint or several, to which any Participant may become subject under the Securities
Act, the Exchange Act or otherwise, insofar as any such losses, claims, damages or liabilities (or actions in respect thereof) arise out
of or are based upon:

 

i.                   
any untrue statement or alleged untrue statement of any material fact contained in any Registration Statement (or any amendment
thereto) or Prospectus (as amended or supplemented if the Company shall have furnished any amendments or supplements thereto); or

 

ii.                 
the omission, or alleged omission to state, in any Registration Statement (or any amendment thereto) or Prospectus (as amended
or supplemented if the Company shall have furnished any amendments or supplements thereto), a material fact required to be stated therein
or necessary to make the statements therein (in the case of any such Prospectus, in the light of the circumstances under which such statement
was made) not misleading;

 

and agree (subject to the limitations set forth in the proviso to this
sentence) to reimburse, as incurred, the Participant for any reasonable legal or other expenses incurred by the Participant in connection
with investigating, defending against or appearing as a third-party witness in connection with any such loss, claim, damage, liability
or action; provided, however, that the

 

    21 

     

    

Company will not be liable in any case under this Section 7(a) to the
extent that any such loss, claim, damage or liability (A) arises out of or is based upon any untrue statement or omission or alleged untrue
statement or alleged omission made in any Registration Statement (or any amendment thereto) or Prospectus (as amended or supplemented
if the Company shall have furnished any amendments or supplements thereto) or any amendment or supplement thereto in reliance upon and
in conformity with written information relating to any Participant furnished to the Company by such Participant specifically for use therein
or (B) arising from an offer or sale of Securities or Exchange Securities occurring during a Shelf Suspension Period by a Holder or Participating
Broker-Dealer to whom the Company theretofore provided notice thereof pursuant to Section 5(c) hereof. The indemnity provided for in this
Section 7 will be in addition to any liability that the Company may otherwise have to the indemnified parties. The Company shall not be
liable under this Section 7 to any indemnified party regarding any settlement or compromise or consent to the entry of any judgment with
respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought
hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise
or consent is consented to by the Company, which consent shall not be unreasonably withheld.

 

(b)              
Each Participant, severally and not jointly, agrees to indemnify and hold harmless the Company, its directors (or equivalent),
officers, representatives, agents and employees and each Person, if any, who controls the Company within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act against any losses, claims, damages or liabilities to which the Company or any such
director, officer, representative, agent, employee or controlling person may become subject under the Securities Act, the Exchange Act
or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i)
any untrue statement or alleged untrue statement of any material fact contained in any Registration Statement or Prospectus or any amendment
or supplement thereto, (ii) the omission or the alleged omission to state therein a material fact necessary to make the statements therein
not misleading (in the case of any such Prospectus, in the light of the circumstances under which such statements were made), in each
case to the extent, but only to the extent, that such untrue statement or omission or alleged untrue statement or alleged omission was
made in reliance upon and in conformity with written information concerning such Participant furnished to the Company by or on behalf
of such Participant specifically for use therein or (iii) an offer or sale of Securities or Exchange Securities occurring during a Shelf
Suspension Period by a Holder or Participating Broker-Dealer to whom the Company theretofore provided notice thereof pursuant to Section
5(c) hereof; and subject to the limitation set forth immediately preceding this clause, will reimburse, as incurred, any reasonable legal
or other expenses incurred by the Company or any such director, officer, representative, agent, employee or controlling person in connection
with investigating or defending against or appearing as a third-party witness in connection with any such loss, claim, damage, liability
or action in respect thereof. The indemnity provided for in this Section 7 will be in addition to any liability that the Participants
may otherwise have to the indemnified parties. A Participant shall not be liable under this Section 7 to any indemnified party regarding
any settlement or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or
proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual
or potential parties to such claim or action) unless such settlement, compromise or consent is consented to by such Participant, which
consent shall not be unreasonably withheld.

 

    22 

     

    

(c)              
Promptly after receipt by an indemnified party under this Section 7 of notice of the commencement of any action, such indemnified
party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section 7, notify the indemnifying
party of the commencement thereof in writing; but the omission to so notify the indemnifying party (i) will not relieve it from any liability
under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture
by the indemnifying party of substantial rights and defenses and (ii) will not, in any event, relieve the indemnifying party from any
obligations to any indemnified party other than the indemnification obligation provided in paragraphs (a) and (b) above. The indemnifying
party shall be entitled to appoint counsel (including local counsel in each applicable jurisdiction) of the indemnifying party’s
choice at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought
(in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel, other than
local counsel if not appointed by the indemnifying party, retained by the indemnified party or parties except as set forth below); provided,
however, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party’s
election to appoint counsel (including local counsel in each applicable jurisdiction) to represent the indemnified party in an action,
the indemnified party shall have the right to employ separate counsel (including local counsel in each applicable jurisdiction), and the
indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel if (i) the use of counsel chosen by the
indemnifying party to represent the indemnified party would present such counsel with a conflict of interest (based on the advice of counsel
to the indemnified party); (ii) such action includes both the indemnified party and the indemnifying party and the indemnified party shall
have reasonably concluded (based on the advice of counsel to the indemnified party) that there may be legal defenses available to it and/or
other indemnified parties that are different from or additional to those available to the indemnifying party; (iii) the indemnifying party
shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable
time after notice of the institution of such action; or (iv) the indemnifying party shall authorize the indemnified party to employ separate
counsel at the expense of the indemnifying party. It is understood and agreed that the indemnifying party shall not, in connection with
any proceeding or separate but related or substantially similar proceedings in the same jurisdiction arising out of the same general allegations
or circumstances, be liable for the reasonable fees and expenses of more than one separate firm (in addition to one local counsel in each
applicable jurisdiction) representing the indemnified parties under paragraph (a) or paragraph (b) of this Section 7, as the case may
be, who are parties to such action or actions. Any such separate firm for any Participants shall be designated in writing by Participants
who sold a majority in interest of the Transfer Restricted Securities and Exchange Securities sold by all such Participants, in the case
of paragraph (a) of this Section 7, or the Company, in the case of paragraph (b) of this Section 7. An indemnifying party shall not, without
the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any
pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether
or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent
includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and
does not include any statement as to, or any admission of, fault, culpability or failure to act by or on behalf of any indemnified party.
All fees and expenses reimbursed pursuant to this paragraph (c) shall be reimbursed as they are incurred and following a written request
therefor.

 

    23 

     

    

(d)              
After notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof and approval
by such indemnified party of counsel appointed to defend such action, the indemnifying party shall not be liable to such indemnified party
under this Section 7 for any legal or other expenses, other than reasonable costs of investigation, subsequently incurred by such indemnified
party in connection with the defense thereof, unless (i) the indemnified party shall have employed separate counsel in accordance with
the third sentence of paragraph (c) of this Section 7, or (ii) the indemnifying party has authorized in writing the employment of counsel
for the indemnified party at the expense of the indemnifying party. After such notice from the indemnifying party to such indemnified
party, the indemnifying party will not be liable for the costs and expenses of any settlement of such action effected by such indemnified
party without the prior written consent of the indemnifying party (which consent shall not be unreasonably withheld), unless such indemnified
party waived in writing its rights under this Section 7, in which case the indemnified party may effect such a settlement without such
consent.

 

(e)              
In circumstances in which the indemnity agreement provided for in the preceding paragraphs of this Section 7 is unavailable to,
or insufficient to hold harmless, an indemnified party in respect of any losses, claims, damages or liabilities (or actions in respect
thereof) (other than for the reasons specified in Section 7(a) or 7(b) hereof, including by virtue of the failure of an indemnified party
to notify the indemnifying party of its right to indemnification pursuant to paragraph (a) or (b) of this Section 7, where such failure
materially prejudices the indemnifying party (through the forfeiture of substantial rights or defenses)), each indemnifying party, in
order to provide for just and equitable contribution, shall contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect (i) the
relative benefits received by the indemnifying party or parties, on the one hand, and the indemnified party, on the other, from the offering
of the Securities, or (ii) if the allocation provided by the foregoing clause (i) is not permitted by applicable law, not only such relative
benefits but also the relative fault of the indemnifying party or parties, on the one hand, and the indemnified party, on the other, in
connection with the statements or omissions or alleged statements or omissions that resulted in such losses, claims, damages or liabilities
(or actions in respect thereof). The relative benefits received by the Company, on the one hand, and the Participants, on the other, shall
be deemed to be in the same proportion that the total net proceeds from the offering (before deducting expenses) of the Securities received
by the Company bear to the total discounts and commissions received by the Participants in connection with the initial sale of the Securities
by the Company (or if such Participant did not receive a discount from the Company with respect to the initial sale of the Securities
by the Company, the net proceeds received by such Participant from the sale of Securities, Exchange Securities or Private Exchange Notes
pursuant to such Registration Statement). The relative fault of the parties shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company, on the one hand, or the Participants, on the other hand, the parties’ relative intent, knowledge, access
to

 

    24 

     

    

information
and opportunity to correct or prevent such statement or omission or alleged statement or omission, and any other equitable considerations
appropriate in the circumstances. The parties agree that it would not be equitable if the amount of such contribution were determined
by pro rata or per capita allocation or by any other method of allocation that does not take into account the equitable considerations
referred to in the first sentence of this paragraph (e). Notwithstanding any other provision of this paragraph (e), no Participant shall
be obligated to make contributions hereunder that in the aggregate exceed the total discounts, commissions and other compensation or
net proceeds, as applicable, on the sale of Securities received by such Participant in connection with the sale of the Securities, less
the aggregate amount of any damages that such Participant has otherwise been required to pay by reason of the untrue or alleged untrue
statements or the omissions or alleged omissions to state a material fact, and no person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. For purposes of this paragraph (e), each person, if any, who controls a Participant within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as the Participants, and each director,
member or manager, as applicable, of the Company, each officer of the Company, and each person, if any, who controls the Company within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the same rights to contribution as the
Company.

 

		8.	Rule 144A

 

The Company covenants and agrees that it will use
its commercially reasonable efforts to file the reports required to be filed by them under the Securities Act and the Exchange Act and
the rules and regulations adopted by the SEC thereunder in a timely manner in accordance with the requirements of the Securities Act and
the Exchange Act and, if at any time the Company is not required to file such reports and do not otherwise file such reports pursuant
to the terms of the Indenture, the Company shall, upon the request of any Holder or beneficial owner of Transfer Restricted Securities,
make available the information required by Rule 144A(d)(4) under the Securities Act in order to permit sales pursuant to Rule 144A.

 

		9.	NO Underwritten Registrations

 

The Company shall not be required to assist in an
underwritten offering of the Transfer Restricted Securities.

 

		10.	Miscellaneous

 

(a)              
No Inconsistent Agreements. The Company has not as of the date hereof entered, and the Company shall not after the date
of this Agreement enter, into any agreement with respect to any of the Company’s securities that is inconsistent with the rights
granted to the Holders of Transfer Restricted Securities in this Agreement or otherwise conflicts with the provisions hereof. The rights
granted to the Holders hereunder do not in any way conflict with and are not inconsistent with the rights granted to the holders of the
Company’s other issued and outstanding securities, if any, under any such agreements.

 

    25 

     

    

        
 

 

(b)              
Adjustments Affecting Transfer Restricted Securities. The Company shall not, directly or indirectly, take any action with
respect to the Transfer Restricted Securities as a class that would adversely affect the ability of the Company to consummate the Exchange
Offer on the terms specified herein or effect any Shelf Registration required by this Agreement.

 

(c)              
Amendments and Waivers. The provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from the provisions hereof may not be given, otherwise than with the prior written consent of (I) the Company, and (II)
(A) the Holders of not less than a majority in aggregate principal amount of the then outstanding Transfer Restricted Securities and (B)
in circumstances that would adversely affect the Participating Broker-Dealers, the Participating Broker-Dealers holding not less than
a majority in aggregate principal amount of the Exchange Securities held by all Participating Broker-Dealers; provided, however, that
Section 7 hereof and this Section 10(c) may not be amended, modified or supplemented, the rate at which Additional Interest accrues pursuant
to Section 4(a) hereof may not be reduced, and the time for payment of Additional Interest pursuant to Section 4(a) hereof may not be
changed, in each case, without the prior written consent of each Holder and each Participating Broker-Dealer (including any person who
was a Holder or Participating Broker-Dealer of Transfer Restricted Securities or Exchange Securities, as the case maybe, disposed of pursuant
to any Registration Statement) affected by any such amendment, modification or supplement; provided, further, that no consent is
necessary from any Holder or Participating Broker-Dealer in the event that this Agreement is amended, modified or supplemented for the
purpose of curing any ambiguity, defect or inconsistency that does not adversely affect the rights of any Holder or Participating Broker-Dealer
(as applicable), as determined by the Company in its reasonable discretion. Notwithstanding the foregoing, (A) a waiver or consent to
depart from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders whose Securities are being
tendered pursuant to the Exchange Offer and that does not affect directly or indirectly the rights of other Holders whose Securities are
not being tendered pursuant to such Exchange Offer may be given by the Holders of a majority of the outstanding principal amount of Transfer
Restricted Securities being tendered or registered and (B) a waiver or consent to depart from the provisions hereof with respect to a
matter that relates exclusively to the rights of Holders of Transfer Restricted Securities whose Securities are being sold pursuant to
a Registration Statement and that does not directly or indirectly affect, impair, limit or compromise the rights of other Holders of Transfer
Restricted Securities may be given by Holders of at least a majority in aggregate principal amount of the Transfer Restricted Securities
being sold pursuant to such Registration Statement.

 

(d)              
Notices. All notices and other communications (including, without limitation, any notices or other communications to the
Trustee) provided for or permitted hereunder shall be made in writing by hand-delivery, registered first-class mail, next-day air courier,
facsimile or electronic mail:

 

(i)                
If to a Holder of the Transfer Restricted Securities or any Participating Broker-Dealer, at the most current address of such Holder
or Participating Broker-Dealer, as the case may be, set forth on the records of the registrar under the Indenture, with a copy in like
manner to the Initial Purchasers as follows:

 

    26 

     

    

 

Morgan Stanley & Co. LLC

1585 Broadway

New York, New York 10036

 

J.P. Morgan Securities LLC

383 Madison Avenue

New York, New York 10179

 

BofA Securities, Inc.

One Bryant Park

New York, New York 10036

 

Barclays Capital Inc.

745 Seventh Avenue

New York, New York 10019

 

with a copy to:

 

Skadden, Arps, Slate, Meagher & Flom LLP

One Manhattan West

New York, New York 10001

Facsimile: (917) 777-3712

Attention: Ryan J. Dzierniejko, Michael J. Hong

 

(ii)           
If to the Initial Purchasers, at the address specified in Section 10(d)(i) hereof;

 

(iii)          
If to the Company, at the address as follows:

 

Meta Platforms, Inc.

1601 Willow Road

 

Menlo Park, California 94025

Facsimile: (650) 543-4800

Attention: Corporate Secretary (a copy of which shall also be sent via e-mail to: CorporateSecretary@fb.com)

 

with a copy to:

Davis Polk & Wardwell LLP

450 Lexington Avenue

 

New York, New York 10017

Facsimile: (212) 701-5111

Attention: Michael Kaplan, Derek Dostal

 

All such notices and communications shall be deemed
to have been duly given: when delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage
prepaid, if mailed; one Business Day after being timely delivered to a next-day air courier; and upon receipt of confirmation, if sent
by facsimile or electronic mail.

 

    27 

     

    

Copies of all such notices, demands or other communications
shall be concurrently delivered by the Person giving the same to the Trustee at the address and in the manner specified in such Indenture.

 

(e)               
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties, including, without limitation, and without the need for an express assignment, subsequent Holders of Transfer
Restricted Securities; provided, however, that this Agreement shall not inure to the benefit of or be binding upon a successor
or assign of a Holder unless and to the extent such successor or assign acquired Transfer Restricted Securities from such Holder; and
provided, further, that nothing herein shall be deemed to permit any assignment, transfer or other disposition of Transfer Restricted
Securities in violation of the terms of the Purchase Agreement or the Indenture.

 

(f)              
Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts,
each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.

 

(g)              
Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the
meaning hereof.

 

hi)                
Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. EACH
OF THE PARTIES HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT.

 

ij)                
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their respective
commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

 

(j)              
Securities Held by the Company or Any of its Affiliates. Whenever the consent or approval of Holders of a specified percentage
of Transfer Restricted Securities is required hereunder, Transfer Restricted Securities held by the Company or any of its controlled affiliates
(as such term is defined in Rule 405) shall not be counted in determining whether such consent or approval was given by the Holders of
such required percentage.

 

kl)                
Third-Party Beneficiaries. Holders of Transfer Restricted Securities and Participating Broker-Dealers are intended third-party
beneficiaries of this Agreement, and this Agreement may be enforced by such Persons to the extent necessary to protect the rights of the
Holders hereunder.

 

    28 

     

    

 

(l)              
Entire Agreement. This Agreement, together with the Purchase Agreement and the Indenture, is intended by the parties as
a final and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein
and therein and any and all prior oral or written agreements, representations, or warranties, contracts, understandings, correspondence,
conversations and memoranda between the Holders and Initial Purchasers, on the one hand, and the Company, on the other hand, or between
or among any agents, representatives, parents, subsidiaries, affiliates, predecessors in interest or successors in interest with respect
to the subject matter hereof and thereof are merged herein and replaced hereby.

 

[Remainder of Page Intentionally Blank]

 

    29 

     

    

IN WITNESS WHEREOF, the parties have executed this
Agreement as of the date first written above.

 

 

	 	META PLATFORMS, INC.
	 	 
	 	By:	/s/ David M. Wehner
	 	Name:	David M. Wehner
	 	Title:	Chief Financial Officer

 

 

[Signature Page to the Registration Rights Agreement]

 

     

     

    

The foregoing Agreement is hereby confirmed and accepted
as of the date first written above.

 

	 	
    Morgan Stanley & Co. LLC

    

    J.P. Morgan Securities LLC

    

    BofA Securities, Inc.

    

    Barclays Capital Inc.

    

    Acting severally on behalf of themselves
    and the several Initial Purchasers

     

	 	
    Morgan Stanley & Co. LLC

     

	 	By:	/s/ Julie McBrien
	 	Name:	Julie McBrien
	 	Title:	Vice President
	 	 	 
	 	 	 
	 	
    J.P. Morgan Securities LLC

     

	 	By:	/s/ Som Bhattacharyya
	 	Name:	Som Bhattacharyya
	 	Title:	Executive Director
	 	 
	 	 
	 	
    BofA Securities, Inc.

     

	 	By:	/s/ Laurie Campbell
	 	Name:	Laurie Campbell
	 	Title:	Managing Director
	 	 	 
	 	 	 
	 	
    Barclays Capital Inc.

     

	 	By:	/s/ Matt Bannon
	 	Name:	Matt Bannon
	 	Title:	Managing Director

 

 

[Signature Page to the Registration Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]